Apparatus for UV flowable dielectric

Information

  • Patent Grant
  • 11270896
  • Patent Number
    11,270,896
  • Date Filed
    Thursday, July 11, 2019
    5 years ago
  • Date Issued
    Tuesday, March 8, 2022
    2 years ago
Abstract
Provided are methods and apparatus for ultraviolet (UV) assisted capillary condensation to form dielectric materials. In some embodiments, a UV driven reaction facilitates photo-polymerization of a liquid phase flowable material. Applications include high quality gap fill in high aspect ratio structures and pore sealing of a porous solid dielectric film. According to various embodiments, single station and multi-station chambers configured for capillary condensation and UV exposure are provided.
Description
INCORPORATION BY REFERENCE

An Application Data Sheet is filed concurrently with this specification as part of the present application. Each application that the present application claims benefit of or priority to as identified in the concurrently filed Application Data Sheet is incorporated by reference herein in its entirety and for all purposes.


BACKGROUND

It is often necessary in semiconductor processing to fill high aspect ratio gaps with insulating material. This is the case for shallow trench isolation (STI), inter-metal dielectric (IMD) layers, inter-layer dielectric (ILD) layers, pre-metal dielectric (PMD) layers, passivation layers, etc. As device geometries shrink and thermal budgets are reduced, void-free filling of narrow width, high aspect ratio (AR) features (e.g., AR>6:1) becomes increasingly difficult due to limitations of existing deposition processes.


SUMMARY

One aspect of the disclosure may be implemented in an apparatus including a multi-station chamber including chamber walls and a first station and a second station at least partially within the chamber walls; the first station having a first substrate support and a showerhead located above the first substrate support; a gas distribution system configured to deliver reactants to the first station via the showerhead; the second station having a second substrate support and an ultraviolet light configured to illuminate a UV exposure area on the second substrate support; and a mechanism to transfer a substrate from the first station to the second station.


In some embodiments, the apparatus may further including a heating system and cooling system, wherein the heating system is configured to heat an inner surface of the chamber walls and the cooling system is configured to cool the first substrate support. In some embodiments, the ultraviolet light is located above the second substrate support.


In some embodiments, the apparatus may further include a controller having machine readable instructions to: distribute a gas comprising a dielectric precursor to the first station while a substrate is present in the first station; maintain the first substrate support at a temperature between −20° C. and 100° C. while the dielectric precursor is in the first station; after distributing the gas to the first station, transfer the substrate to the second station; and expose the substrate to UV radiation. The instructions may further include instructions for maintaining the second substrate support at a temperature of between −20° C. and 100° C. while the substrate is in the second station.


Another aspect of the disclosure may be implemented in an apparatus including a chamber including a substrate support; an ultraviolet radiation source; a showerhead configured to distribute a reactant to the chamber; and a controller comprising machine readable instructions for introducing a dielectric precursor the chamber via the showerhead at a support temperature of between about −20° C. and 100° C. to thereby form a flowable film; and exposing the flowable film to UV radiation.


In some embodiments, the chamber is a single-station chamber. In some embodiments, the chamber is a multi-station chamber. In some embodiments, the ultraviolet radiation source is embedded within or mounted to the showerhead. In some embodiments, the apparatus has a plurality of ultraviolet radiation sources evenly distributed across the showerhead. In some embodiments, the ultraviolet radiation source is part of a second chamber connected to the chamber. The substrate support may be rotatable.


These and other aspects of the disclosure are described further below.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a flow diagram illustrating an example of a process for forming a flowable dielectric film.



FIGS. 2A-2D show examples of schematic cross-sectional illustrations of substrates including gaps that may be filled with a flowable dielectric film.



FIG. 3 is a schematic illustration of a graph showing an example of a critical dimension-partial pressure deposition curve.



FIGS. 4A and 4B are flow diagrams illustrating examples processes for forming a flowable dielectric film.



FIG. 5 is a schematic illustration of pore sealing according to certain implementations.



FIG. 6 is an example of a reaction mechanism that may be employed in certain implementations.



FIG. 7 shows an image 701 of uniform densified flowable film formed with in-situ UV exposure.



FIG. 8 shows Fourier transform infrared spectroscopy (FTIR) spectra for films deposited from TVTMCTS with no oxidant employed and in-situ UV exposure during the deposition



FIGS. 9, 10, 11A, 11B, 12A, and 12B are schematic illustrations of apparatus suitable to practice the methods described herein.





DETAILED DESCRIPTION OF THE INVENTION
Introduction

Aspects of the present invention relate to forming flowable dielectric films on substrates and related apparatuses. Some embodiments include filling high aspect ratio gaps with insulating material. Some embodiments include filling small pores with insulating material. For ease of discussion, the description below refers chiefly to flowable silicon oxide films, however the processes described herein may also be used with other types of flowable dielectric films. For example, the dielectric film may be primarily silicon nitride, with Si—N and N—H bonds, primarily silicon oxynitrides, primarily silicon carbide, or primarily silicon oxycarbide films.


It is often necessary in semiconductor processing to fill high aspect ratio gaps with insulating material. This is the case for shallow trench isolation (STI), inter-metal dielectric (IMD) layers, inter-layer dielectric (ILD) layers, pre-metal dielectric (PMD) layers, passivation layers, etc. As device geometries shrink and thermal budgets are reduced, void-free filling of narrow width, high aspect ratio (AR) features becomes increasingly difficult due to limitations of existing deposition processes. In certain embodiments, the methods pertain to filling high aspect (AR) ratio (typically at least 6:1, for example 7:1 or higher), narrow width (e.g., sub-50 nm) gaps. In certain embodiments, the methods pertain to filling low AR gaps (e.g., wide trenches). Also in certain embodiments, gaps of varying AR may be on the substrate, with the embodiments directed at filling low and high AR gaps.


In a particular example, a PMD layer is provided between the device level and the first layer of metal in the interconnect level of a partially fabricated integrated circuit. The methods described herein include dielectric deposition in which gaps, (e.g., the gaps between gate conductor stacks) are filled with dielectric material. In another example, the methods are used for shallow trench isolation processes in which trenches are formed in semiconductor substrates to isolate devices. The methods described herein include dielectric deposition in these trenches. The methods can also be used for back end of line (BEOL) applications, in addition to front end of line (FEOL) applications. These can include filling gaps at an interconnect level.


Still further, in certain embodiments, the methods pertain to pore sealing of porous dielectric films using flowable dielectric material. For example, the methods can involve pore sealing of a porous ultra low-k (ULK) film in BEOL processing of semiconductor devices.


The methods described herein can be used for any type of flowable dielectric process including undoped silica glass (USG), low-k, and ultra-low k ULK flowable oxide.


The term “semiconductor device” as used herein refers to any device formed on a semiconductor substrate or any device possessing a semiconductor material. In many cases, a semiconductor device participates in electronic logic or memory, or in energy conversion. The term “semiconductor device” subsumes partially fabricated devices (such as partially fabricated integrated circuits) as well as completed devices available for sale or installed in particular apparatus. In short, a semiconductor device may exist at any state of manufacture that employs a method of the subject matter disclosed herein or possesses a structure of this subject matter disclosed herein.


Vapor-phase reactants are introduced to a deposition chamber to deposit the flowable dielectric films. As-deposited, the flowable dielectric films generally have flow characteristics that can provide consistent fill of at least the opening of a pore. The term “as-deposited flowable dielectric film” refers to a flowable dielectric film prior to any post-deposition treatments, densification, cure or anneal. An as-deposited flowable dielectric film may be characterized as a soft jelly-like film, a gel, a sol, or a flowable film. In some embodiments, the as-deposited film is a solid, non-liquid film that is liquid and flowable only during the deposition process; as soon as the deposition process stops, it is a solid film.



FIG. 1 is a process flow diagram illustrating one example of a process for forming a flowable dielectric film. The process can be used in the fabrication of semiconductor devices, displays, LEDs, photovoltaic panels and the like. As noted above, in semiconductor device fabrication, the process can be used for BEOL applications and FEOL applications. In some embodiments, the processes may be used for applications in which high aspect ratio gaps are filled with insulating material. Examples include shallow trench isolation (STI), formation of inter-metal dielectric (IMD) layers, inter-layer dielectric (ILD) layers, pre-metal dielectric (PMD) layers, and passivation layers, and filling gaps at the interconnect level. In some embodiments, the process can be used for pore-sealing. Further examples include formation of sacrificial layers for air gap formation or lift-off layers.


First, a substrate including a gap is provided to a deposition chamber (block 101). Examples of substrates include semiconductor substrates, such as silicon, silicon-on-insulator (SOI), gallium arsenide and the like, as well as glass and plastic substrates. The substrate includes at least one and typically more than one gap to be filled, with the one or more gaps being trenches, holes, vias, pores, or other unfilled features on the substrate.



FIGS. 2A-2D show examples of schematic cross-sectional illustrations of substrates 201 including gaps 203. Turning first to FIG. 2A, a gap 203 can be defined by sidewalls 205 and a bottom 207. It may be formed by various techniques, depending on the particular integration process, including patterning and etching blanket (i.e., planar) layers on a substrate or by building structures having gaps there-between on a substrate. In certain embodiments a top of the gap 203 can be defined as the level of planar surface 209. Specific examples of gaps are provided in FIGS. 2B and 2C. In FIG. 2B, a gap 203 is shown between two gate structures 202 on a substrate 201. The substrate 201 may be a semiconductor substrate and may contain n-doped and p-doped regions (not shown). The gate structures 202 include gates 204 and silicon nitride or silicon oxy-nitride layer 211. In certain embodiments, the gap 203 is re-entrant, i.e., the sidewalls taper inwardly as they extend up from the bottom 207 of the gap; gap 203 in FIG. 2B is an example of a re-entrant gap.



FIG. 2C shows another example of gap to be filled. In this example, gap 203 is a trench formed in silicon substrate 201. The sidewalls and bottom of the gap are defined by liner layer 216, e.g., a silicon nitride or silicon oxynitride layer. The structure also includes pad silicon oxide layer 215 and pad silicon nitride layer 213. FIG. 2C is an example of a gap that may be filled during a STI process. In certain cases, liner layer 216 is not present. In certain embodiments, the sidewalls of silicon substrate 201 are oxidized.



FIGS. 2B and 2C provide examples of gaps that may be filled with dielectric material in a semiconductor fabrication process. The processes described herein may be used to fill any gap that requires dielectric fill. In certain embodiments, the gap critical dimension is the order of about 1-50 nm, in some cases between about 2-30 nm or 4-20 nm, e.g. 13 nm. Critical dimension refers to the width of the gap opening at its narrowest point. In certain embodiments, the aspect ratio of the gap is between 3:1 and 60:1. According to various embodiments, the critical dimension of the gap is 32 nm or below and/or the aspect ratio is at least about 6:1.


As indicated above, a gap may be defined by a bottom surface and sidewalls. The term sidewall or sidewalls may be used interchangeably to refer to the sidewall or sidewalls of a gap of any shape, including a round hole, a long narrow trench, etc. In some embodiments, the processes described herein may be used to form flowable films on planar surfaces in addition to or instead of in gaps.


Also in some embodiments, the gap may be a pore. FIG. 2D shows an example of a structure including an embedded metal line 251 in a first dielectric layer 253. An etched porous dielectric layer 255 overlies the first dielectric layer 253 and, optionally an etch stop layer 261 such as a silicon carbide, silicon oxycarbide, silicon nitride, or silicon oxynitride etch stop layer. The etched porous dielectric layer 255 is etched in previous processing to define a recess 257 and expose the metal line 251. An exposed surface 262 of the etched porous dielectric layer 255 includes the surface of the recess 257.


The etched porous dielectric layer 255 is a porous dielectric having connected porosity. An enlarged schematic view of a cross-section of a portion of the etched porous dielectric layer 255 is depicted. The etched second dielectric layer includes gaps 203 that are connected (in or out of the plane of the cross-section) pores and thus exposed at the surface 212 to the ambient conditions.


A portion 265 of the etched porous dielectric layer 255 includes sealant material 266 deposited by a flowable dielectric deposition process. An enlarged schematic view of a cross-section of a portion of the sealed etched porous dielectric layer 255 is depicted. Gaps 203 that were previously open to the ambient are sealed with the sealant material 216 deposited from the flowable dielectric deposition process. Depending on whether or not the field regions of the etched porous dielectric layer 255 are capped or not with another material (e.g., such an etch stop or hard mask layer), pores open to the field region (not shown) may also be sealed in addition to the pores open to the recess 257. Subsequent operations may involve optionally cleaning or treating the surface of the metal line 251, depositing a barrier layer, and filling the recess 257 with a conductive material. If the pores are not sealed, any of these operations may result in precursor and/or metal penetration into the gaps 203, which can result in lower break down voltage and failure.


The porous dielectric film may be for example, a ULK film, having a dielectric constant of 2.4 or less. Examples of ULK films include carbon doped oxide (CDO) films, zeolite films, and polymer films.


The porosity of a dielectric film may be connected, and may include pores that are introduced by removal of a porogen from a dielectric matrix and/or pores that are inherent to the dielectric matrix. For example, a CDO matrix may have porosity due the incorporation of methyl or other organic groups. The porous dielectric film may include mesoporosity and/or microporosity. Mesoporosity generally refers to pore sizes of 2 nm-50 nm and microporosity to pore sizes less than 2 nm. In dielectrics having connected porosity, the size of at least some of the connected pores may be on a continuum with micropores having sizes on the order of Angstroms to nanometers, connected to mesopores having sizes on the order of nanometers to tens of nanometers. Although the methods may also be used to seal unconnected pores and provided smooth deposition surfaces, particular use may be found in sealing connected pores that left unsealed provide a diffusion pathway through a film. Porosity characteristics at the exposed surface may depend on the etch process as well as on the particular film and method of deposition.


Returning to FIG. 1, the deposition surface may be or include one or multiple materials. For example, sidewall and bottom surfaces that define a gap may be one material or include multiple materials. Referring to FIG. 2C, for example, if a liner layer 216 is present, it may be the only deposition surface. However, if the liner layer 216 is not present, the deposition surface can include the silicon substrate 201, the pad silicon oxide layer 215 and the pad silicon nitride layer 213. Examples of gap surface materials, including sidewall and/or bottom materials, include silicon nitrides, silicon oxides, silicon carbides, silicon oxynitrides, silicon oxycarbides, silicides, silicon germanium, as well as bare silicon or other semiconductor material. Particular examples include SiN, SiO2, SiC, SiON, NiSi, and polysilicon. Further examples of gap materials used in BEOL processing include copper, tantalum, tantalum nitride, titanium, titanium nitride, ruthenium and cobalt. In certain embodiments, prior to flowable dielectric deposition, the gap is provided with a liner, barrier or other type of conformal layer formed in the gap, such that the deposition surfaces include the conformal layer. In some embodiments, the deposition surfaces of a substrate are exposed to a treatment. Examples of pre-deposition treatments are provided further below.


Returning to FIG. 1, a process gas including a dielectric precursor is flowed into the deposition chamber (block 103). As described below, the process gas may include an optional co-reactant. A flowable dielectric film is deposited into the gap (block 105).


In some embodiments, the flowable dielectric film is selectively deposited in the gap. Selective deposition refers to a process that preferentially deposits in a location without or prior to depositing in other locations. In block 105, the flowable dielectric material preferentially deposits inside the gaps rather than outside the gaps. In the context of pore sealing, the dielectric preferentially deposits in at least the opening of the pores of the porous dielectric material than outside the pores of the porous dielectric material, for example, on the discontinuous external surface of the porous dielectric and on the exposed metal surfaces in FIG. 2D. As such, deposition of flowable dielectric material on other exposed surfaces such as on the field regions may be non-existent or substantially non-existent, with one of ordinary skill in the art understanding that there may be some small areas of film nucleating on these surfaces.


According to various implementations, block 105 may involve a mechanism that deposits preferentially in the smallest features, be it a via hole, trench, or the small openings of pores in the porous dielectric, without or prior to forming a continuous film outside of these features.


In some implementations, block 105 exploits a thermodynamic effect in which a flowable dielectric material remains selectively condensed in the gaps, as the smallest spaces available for formation of the flowable dielectric material. As such the flowable dielectric material is selectively deposited in these gaps. In some pore sealing applications, the smallest space available is the openings to the pores such that flowable dielectric material is deposited in the openings but does not completely fill the pores. (In some implementations, the thermodynamic effect can be exploited to evaporate flowable dielectric material deposited outside the pores, while the flowable material in the pores remains condensed.)


Depositing a flowable oxide film, for example, can involve exposing the substrate to gaseous reactants including a dielectric precursor such that a condensed flowable film forms in the gap. The deposition generally occurs in non-plasma conditions, though in certain embodiments, plasma-enhanced conditions may be employed. In other embodiments, reactive species from a downstream plasma may be present even though the substrate is not directly exposed to a plasma.


The dielectric precursor is a silicon-containing compound. In some implementations, the dielectric precursor is a compound that undergoes photo-induced polymerization and may be a cyclic siloxane, a cyclic silazane, or a linear or cyclic silicon-containing compound that includes unsaturated hydrocarbon groups.


An oxidant such as a peroxide, ozone, oxygen, water, etc. may be optionally flowed. In some embodiments, the oxidant is a non-hydroxyl-forming oxidant such as ozone or oxygen.


In some implementations, a SiCOH film is formed, using for example a dielectric precursor including one or more Si—C bonds. In some implementations, the flowable dielectric film is a silicon and nitrogen-containing film, such as silicon nitride or silicon oxynitride deposited by introducing vapor phase reactants to a deposition chamber at conditions such that they react to form a flowable film. The nitrogen incorporated in the film may come from one or more sources, such as a silicon and nitrogen-containing precursor, a nitrogen precursor (for example, ammonia (NH3) or hydrazine (N2H4)), or a nitrogen-containing gas (for example N2, NH3, NO, NO2, or N2O).


Further discussion of deposition chemistries is provided below.


The process gases may be introduced into the reactor simultaneously, or one or more component gases may be introduced prior to the others. U.S. Pat. No. 8,278,224, incorporated by reference herein, provides a description of reactant gas sequences that may be used in accordance with certain embodiments.


Block 105 may involve a capillary condensation mechanism in which the flowable dielectric material preferentially deposits in the smallest features. Due to capillary condensation, flowable process reactants can condense the smallest features even if their partial pressure is below the saturated vapor pressure. This is due to an increased number of van der Waals interactions between vapor phase molecules inside the confined space of capillaries (i.e., the gaps). In pore sealing applications, this allows pore sealing without continuous film deposition on surfaces and bottom up gap fill.


In some implementations, block 105 involves providing a precursor in a vapor phase at a partial pressure below its saturation pressure. The preference for liquid to remain condensed in the small spaces (i.e., capillary condensation) at pressures below the saturation pressure allows for selective deposition in gaps. In some embodiments, the partial pressure may be gradually increased until it approaches point the material begins to condense as a liquid in the gaps, or the precursor may be introduced at this pressure.


Reaction conditions are set to appropriately control the reactant partial pressures relative to their saturated vapor pressures, generally at relatively low temperatures, e.g., −20° C. to 100° C. The capillary condensation in the gaps may be self-limiting, stopping when the gaps are filled or when the pore or other gap openings are sealed.


Pressure and temperature may be varied to adjust deposition time; high pressure and low temperature are generally favorable for quick deposition. High temperature and low pressure will result in slower deposition time. Thus, increasing temperature may involve increasing pressure. In one embodiment, the temperature is about 5° C. and the pressure about 10 Torr. Exposure time depends on reaction conditions as well as pore or other gap size. Deposition rates are from about 100 angstroms/min to 1 micrometer/min according to various embodiments. The substrate is exposed to the reactants under these conditions for a period long enough to deposit a flowable film in the pores or other gaps. In certain embodiments, deposition time is 0.1-5 seconds.


The amount of condensation is controlled by the reactants' partial pressures relative to their saturated vapor pressures (which are constant for a given deposition temperature). The dependence of fill rate on critical dimension can be tuned by varying the partial pressures. In this manner, selectivity can be tuned, improving the capability to deposit in just the pores, other gaps, or as otherwise desired. This is illustrated qualitatively in FIG. 3, which shows a partial pressure-critical dimension deposition curve. At low enough partial pressure of the dielectric precursor, there is no condensation or deposition in features of any size. As the partial pressure is increased, the dielectric precursor condenses in small features, with deposition occurring in increasingly larger feature sizes as the partial pressure is increased. So, for example, to prevent deposition in a 20 nm etched trench of a ULK film while allowing deposition in the pores of the ULK film, the partial pressure of the dielectric precursor is maintained within the cross-hatched portion of the curve.


Returning to FIG. 1, at block 107, the substrate is exposed to UV radiation. As a result, photo-induced polymerization and densification occurs in some embodiments. According to various embodiments, UV exposure may be in-situ or ex-situ with respect to the deposition chamber. FIGS. 4A and 4B show operations in examples of in-situ and ex-situ processes. First, in FIG. 4A, an optional pre-treatment may be performed to activate the substrate and improve wettability (block 401). Examples of pre-treatments are given below. If performed, the pre-treatment may be in the same or a different station or chamber as the subsequent deposition. Next, a dielectric precursor is condensed to yield a liquid dielectric film (block 403). As discussed above, block 403 can involve capillary condensation to preferentially deposit in a pore or other gap. The substrate including the deposited dielectric film is then transferred to a UV station (block 405). The transfer may be under vacuum, for example, with the deposition chamber and UV station connected via a vacuum transfer chamber. The UV station may be in a single station or multi-station UV module. As described below, in some embodiments, the UV station may take place in the same module as the deposition, for example, with deposition taking place at one or more stations of a multi-station module and UV exposure taking place at one or more other stations of the multi-station module. UV exposure is then performed, yielding a dense solid dielectric film (block 407).


In some embodiments, blocks 403 to blocks 407 may be repeated to build up a film of a desired thickness. For example, UV exposure may be performed after each 500 nanometers of flowable dielectric film is deposited.


In various embodiments, dielectric precursors having relatively high boiling points are used such that the substrate can be maintained at a temperature below the boiling point during the process. This allows a dielectric precursor to be condensed and then transferred to the UV station. Temperature during UV exposure should also be kept significantly below the boiling point of the precursor or a condensed product thereof. In some embodiments, the substrate temperature during UV exposure may be at least 25° C. less than the boiling point of a precursor. Boiling points for examples of various precursors are given below.


In FIG. 4B, block 401 is performed as described above. Next, the dielectric precursor is condensed with simultaneous UV exposure to yield a dense solid dielectric film (block 406). UV exposure may be performed after dielectric deposition in-situ in the deposition chamber, in some embodiments.


The UV exposure in FIGS. 4A and 4B is distinct from a post-deposition UV cure operation that may be performed as an alternative to a thermal anneal, for example, to densify sol gel deposited films or remove reaction by products. Such UV cure operations typically take place at much higher temperatures.


Deposition Chemistries and Reaction Mechanisms


Dielectric Precursor


The dielectric precursor is a silicon-containing compound capable of undergoing photo-induced polymerization. Examples of such compounds include cyclic siloxanes, cyclic silazanes, and linear or cyclic silicon-containing precursors containing vinyl or other unsaturated hydrocarbon groups.


Examples of cyclic siloxanes include octamethylcyclotetrasiloxane (OMCTS), tetravinyltetramethylcyclotetrasiloxane (TVTMCTS), tetramethylcyclotetrasiloxane (TMCTS), pentamethylcyclopentasiloxane, and hexamethylcyclotrisiloxane. In some embodiments, cyclic siloxanes can be used in the methods described herein for catalyst-free deposition processes. In some embodiments, cyclic silazanes can be used in the methods described herein for catalyst-free deposition processes.


In some embodiments, dielectric precursors having relatively high boiling points are employed. For example, TMCTS has a boiling point of 135° C., TVTMCTS has a boiling point of 224° C., and OMCTS has a boiling point of 175° C. In some embodiments, dielectric precursors having boiling points of at least 100° C., at least 125° C., at least 150° C., at least 175° C., or at least 200° C. are employed. Boiling points are given at atmospheric pressure.


In pore-sealing applications, the size of the precursor may be tailored to the pore size of the porous dielectric film: it should be small enough that it fits in a pore, but large enough that it does not penetrate too deeply within the porous dielectric. This is illustrated in FIG. 5, in which relatively large cyclic molecules 501 (e.g., van der Waals radius of 1.2 nm) fit within the pores of the porous dielectric 500 to seal the pores, but do not penetrate deeply within the pores. By contrast, smaller linear molecules 503 (e.g., van der Waals radius of 0.5 nm) penetrate the porous dielectric, which can lead to an undesirable increase in dielectric constant. In some embodiments, the van der Waals radius of the molecule is targeted to be about the same as the average pore size. As an example, the average pore size of a CVD ULK film may be 1.0±0.5 nm. A cyclical molecule having a van der Waals radius of at least 0.8 nm may be used. In some embodiments, it may have a van der Waals radius of at least 1.0 nm or 1.2 nm.


According to various embodiments, the as-deposited film is a silicon oxide film or a silicon nitride film, including carbon-containing silicon oxide or silicon nitride films. According to various embodiments, Si—C or Si—N containing dielectric precursors may be used, either as a main dielectric precursor or a dopant precursor, to introduce carbon or nitrogen into the film. Examples of such films include carbon doped silicon oxides and silicon oxynitrides. In some embodiments, the silicon nitride film, including primarily Si—N bonds with N—H bonds.


Co-Reactant


For silicon oxide deposition, an oxidant may be employed in some embodiments. In some other embodiments, oxygen may be supplied solely by a cyclic siloxane precursor, for example, such that the deposition is a single reactant deposition, with no co-reactant. However, an oxidant may be supplied depending on the oxygen content of the particular precursor employed.


If employed, examples of suitable oxidants include, but are not limited to, ozone (O3), peroxides including hydrogen peroxide (H2O2), oxygen (O2), water (H2O), alcohols such as methanol, ethanol, and isopropanol, nitric oxide (NO), nitrous dioxide (NO2) nitrous oxide (N2O), carbon monoxide (CO) and carbon dioxide (CO2). In certain embodiments, a remote plasma generator may supply activated oxidant species.


For silicon nitride deposition, a nitrogen co-reactant may be employed in some embodiments. In some other embodiments, nitrogen may be supplied solely by a cyclic silazane precursor, for example, such that the deposition is a single reactant deposition, with no co-reactant. If employed, examples of suitable nitrogen co-reactants include, but are not limited to, ammonia (NH3), hydrazine (N2H4), nitrogen (N2), NO, NO2, and N2O.


Dopant


One or more dopant precursors, e.g., a carbon-, nitrogen-, fluorine-, phosphorous- and/or boron-containing gas, may be supplied. Sometimes, though not necessarily, an inert carrier gas is present. In certain embodiments, the gases are introduced using a liquid injection system. In certain embodiments, carbon-doped silicon precursors are used, either in addition to another precursor (e.g., as a dopant) or alone. Carbon-doped precursors can include at least one Si—C bond. In certain embodiments, aminosilane precursors are used.


Catalyst


In some embodiments, the deposition may be a catalyst-free deposition that does not employ any one of the below-described catalysts. However, a catalyst may be employed in certain embodiments. In certain embodiments, a proton donor catalyst is employed. Examples of proton donor catalysts include 1) acids including nitric, hydrofluoric, phosphoric, sulfuric, hydrochloric and bromic acids; 2) carboxylic acid derivatives including R—COOH and R—C(═O)X where R is substituted or unsubstituted alkyl, aryl, acetyl or phenol and X is a halide, as well as R—COOC—R carboxylic anhydrides; 3) SixXyHz where x=1-2, y=1-3, z=1-3 and X is a halide; 4) RxSi—Xy where x=1-3 and y=1-3; R is alkyl, alkoxy, alkoxyalkane, aryl, acetyl or phenol; and X is a halide; and 5) ammonia and derivatives including ammonium hydroxide, hydrazine, hydroxylamine, and R—NH2 where R is substituted or unsubstituted alkyl, aryl, acetyl, or phenol.


In addition to the examples of catalysts given above, halogen-containing compounds which may be used include halogenated molecules, including halogenated organic molecules, such as dichlorosilane (SiCl2H2), trichlorosilane (SiCl3H), methylchlorosilane (SiCH3ClH2), chlorotriethoxysilane, chlorotrimethoxysilane, chloromethyldiethoxysilane, chloromethyl dimethoxysilane, vinyltrichlorosilane, diethoxydichlorosilane, and hexachlorodisiloxane. Acids which may be used may be mineral acids such as hydrochloric acid (HCl), sulfuric acid (H2SO4), and phosphoric acid (H3PO4); organic acids such as formic acid (HCOOH), acetic acid (CH3COOH), and trifluoroacetic acid (CF3COOH). Bases which may be used include ammonia (NH3) or ammonium hydroxide (NH4OH), phosphine (PH3); and other nitrogen- or phosphorus-containing organic compounds. Additional examples of catalysts are chloro-diethoxysilane, methanesulfonic acid (CH3SO3H), trifluoromethanesulfonic acid (“triflic”, CF3SO3H), chloro-dimethoxysilane, pyridine, acetyl chloride, chloroacetic acid (CH2ClCO2H), dichloroacetic acid (CHCl2CO2H), trichloroacetic acid (CCl2CO2H), oxalic acid (HO2CCO2H), benzoic acid (C6H5CO2H), and triethylamine.


Examples of other catalysts include hydrochloric acid (HCl), hydrofluoric acid (HF), acetic acid, trifluoroacetic acid, formic acid, dichlorosilane, trichlorosilane, methyltrichlorosilane, ethyltrichlorosilane, trimethoxychlorosilane, and triethoxychlorosilane.


In addition to the catalysts described above, in some implementations, catalysts formulated for BEOL processing applications may be used. Such catalysts are disclosed in U.S. patent application Ser. No. 14/464,196 titled “LOW-K OXIDE DEPOSITION BY HYDROLYSIS AND CONDENSATION”, Aug. 20, 2014 and incorporated herein by reference.


In some implementations, halogen-free acid catalysts may be employed, with examples including 1) acids including nitric, phosphoric, sulfuric acids; and 2) carboxylic acid derivatives including R—COOH where R is substituted or unsubstituted alkyl, aryl, acetyl or phenol, as well as R—COOC—R carboxylic anhydrides.


Also in some implementations, self-catalyzing silane dielectric precursors including aminosilanes, may be used. Aminosilanes that may be used include, but are not limited to, the following: (1) Hx—Si—(NR)y where x=0-3, x+y=4 and R is an organic hydride group. Further examples of self-catalyzed dielectric precursors are provided in U.S. patent application Ser. No. 14/464,196, incorporated herein by reference.


Surfactants


Surfactants may be used to relieve surface tension and increase wetting of reactants on the substrate surface. They may also increase the miscibility of the dielectric precursor with the other reactants, especially when condensed in the liquid phase. Examples of surfactants include solvents, alcohols, ethylene glycol and polyethylene glycol. Difference surfactants may be used for carbon-doped silicon precursors because the carbon-containing moiety often makes the precursor more hydrophobic.


Solvents may be non-polar or polar and protic or aprotic. The solvent may be matched to the choice of dielectric precursor to improve the miscibility in the oxidant. Non-polar solvents include alkanes and alkenes; polar aprotic solvents include acetones and acetates; and polar protic solvents include alcohols and carboxylic compounds.


Examples of solvents that may be introduced include alcohols, e.g., isopropyl alcohol, ethanol and methanol, or other compounds, such as ethers, carbonyls, nitriles, miscible with the reactants. Solvents are optional and in certain embodiments may be introduced separately or with the oxidant or another process gas. Examples of solvents include, but not limited to, methanol, ethanol, isopropanol, acetone, diethylether, acetonitrile, dimethylformamide, and dimethyl sulfoxide, tetrahydrofuran (THF), dichloromethane, hexane, benzene, toluene, isoheptane and diethylether. The solvent may be introduced prior to the other reactants in certain embodiments, either by puffing or normal delivery. In some embodiments, the solvent may be introduced by puffing it into the reactor to promote hydrolysis, especially in cases where the precursor and the oxidant have low miscibility.


Carrier Gases


Sometimes, though not necessarily, an inert carrier gas is present. For example, helium and/or argon, may be introduced into the chamber with one of the compounds described above.


Any of the process gases (silicon-containing precursor, oxidant or other co-reactant, solvent, catalyst, etc.) either alone or in combination with one or more other reactants, may be introduced prior to the remaining reactants. Also in certain embodiments, one or more reactants may continue to flow into the reaction chamber after the remaining reactant flows have been shut off.


Reaction Mechanisms


It has been found that when using certain dielectric precursors, excellent fill may be achieved using the processes described with reference to FIGS. 4A and 4B, even in the absence of a catalyst. In particular, cyclic siloxanes have been found to provide excellent fill even in the absence of a catalyst. It is believed that cyclic silazanes would show similar results.


Without being bound by a particular theory, it is believed that a reaction may transpire by one or more of the following reaction mechanisms.


In some embodiments, the reaction may proceed by a radical-chain mechanism. The radical initiation mechanism is possibly (but not limited to) an adsorbate based radical which adds across oxidizable neighbors such as unsaturated hydrocarbon bonds (such as terminal vinyl, hydrides, or halides) on a siloxane ring that constitute the condensed precursor. Radical propagation progresses to generate a polymer film out of the condensed liquid and release H radicals that recombine to release H2 gas or terminal hydride on reactor surfaces. The final product is a dense low-k oxide film devoid of unsaturated hydrocarbons.


In some embodiments, ring opening and polymerization may include photo dissociation of small amounts of water:

H2O+UV (wavelength less than 242.5)→H++OH


The ring opening and polymerization reactions may proceed as shown in the example of FIG. 6 for a generic cyclic siloxane ring 601. (R represents organic groups and M represents any positively charged moiety (e.g., H+ or NH4+) in the mechanism shown in FIG. 6). A hydroxyl anion generated by the photodissociation attacks a silicon atom of the siloxane ring, which results in the ring opening. Polymerization may then proceed by a SiO attack on another siloxane ring, resulting in opening that ring and polymerizing.


The above-described mechanisms are distinct from sol gel deposition reactions where a precursor and an oxidizer are introduced and condensed onto a substrate where they are allowed to react via hydrolysis and polycondensation to form an oxide film with water and alcohol as byproducts. Advantages to certain described embodiments include reduced or eliminated reliance on post deposition film processing such as thermal or UV cure for film densification and removal of reaction byproducts, excess reactants and adsorbed residual hydroxyl groups to attain the desired physical and electrical properties. As noted above, in some embodiments, the described methods allow flowable dielectric deposition without a catalyst and with a halide-free chemistry. By contrast, hydrolysis and polycondensation depositions typically include use of catalysts that could oxidize metallic components of integrated structures. Halide anions that constitute the catalyst also may be retained in the deposited material and leach out of the low-k layer into other parts of the integrated structure leading to corrosion during integration/further processing/longer times. Residual halide anions can also lead to mobile charges in the dielectric layer, degrading its insulating electrical properties. While organic acid catalysts may address some issues associated with halide catalysts, their use is limited by relatively lower deposition rates and a need for long queue times. Moreover, photosensitivity of uncured films derived from organic acid catalyzed deposition also poses significant post deposition processing challenges. Basic catalysts that are molecularly grafted as part of the precursor or incorporated as an additive result in significantly porous films. Embodiments of the methods described herein can avoid these issues associated with halide, organic acid and base catalysts.


There is typically a presence of pores and voids within material deposited in small dimensions via hydrolsysis-polycondensation deposition. These pores and voids are generated upon removal of byproducts and unreacted material. Embodiments of the methods that do not rely on hydrolysis and polycondensation may not have these voids. The generated by products generated are H radicals and H2 gas, which are easily expunged without leaving voids and pores behind. In particular, single reactant systems (no co-reactant) generate significantly fewer byproducts with no unreacted material left behind at the end of deposition.


According to various embodiments, the films may be deposited at thicknesses of several microns, while still maintaining excellent quality. By contrast, sol gel derived films typically exhibit low hardness and modulus and with tensile stresses that limit maximum thicknesses to about 1 micron before film begins to crack. By contrast, the methods herein may be used to deposit films up to 2 microns before cracking has been observed.


A radical chain reaction mechanism also has a significantly more rapid rate of deposition that a hydrolysis-polycondensation reaction.


Reaction Conditions


Reactions conditions can be such that the dielectric precursor, or a vapor phase product of a reaction thereof, condenses on the substrate surface to form a flowable film. Chamber pressure may be between about 1 and 200 Torr, in certain embodiments, it is between 10 and 75 Torr. In a particular embodiment, chamber pressure is about 10 Torr.


Substrate temperature is between about −20° C. and 100° C. in certain embodiments. In certain embodiments, temperature is between about −20° C. and 30° C., e.g., between −10° C. and 10° C. Pressure and temperature may be varied to adjust deposition time; high pressure and low temperature are generally favorable for quick deposition. High temperature and low pressure will result in slower deposition time. Thus, increasing temperature may involve increasing pressure. In one embodiment, the temperature is about 5° C. and the pressure about 10 Torr. Exposure time depends on reaction conditions as well as pore or other gap size. Deposition rates are from about 100 angstroms/min to 1 micrometer/min according to various embodiments. The substrate is exposed to the reactants under these conditions for a period long enough to deposit a flowable film in the pores or other gaps. In certain embodiments, deposition time is 0.1-5 seconds.


As described above, the amount of condensation may be controlled by the reactants' partial pressures relative to their saturated vapor pressures (which are constant for a given deposition temperature).


Substrate temperature throughout the deposition and simultaneous or subsequent UV exposure is maintained at a level below the boiling point of the dielectric precursors and reaction products thereof. Pressure throughout the deposition and simultaneous or subsequent UV exposure may be sub-atmospheric.


Example UV intensities include 50 W to 500 W of 253.7 nm UV from a broadband (190 nm to 290 nm) source.


Pre-Treatment


According to various embodiments, a pretreatment operation involves exposure to a plasma containing oxygen, nitrogen, helium or some combination of these. The plasma may be downstream or in-situ, generated by a remote plasma generator, such as an Astron® remote plasma source, an inductively-coupled plasma generator or a capacitively-coupled plasma generator. Examples of pre-treatment gases include O2, O3, H2O, NO, NO2, N2O, H2, N2, He, Ar, and combinations thereof, either alone or in combination with other compounds. Examples of chemistries include O2, O2/N2, O2/He, O2/Ar, O2/H2 and H2/He. The particular process conditions may vary depending on the implementation. In alternate embodiments, the pretreatment operation involves exposing the substrate to O2, O2/N2, O2/He, O2/Ar or other pretreatment chemistries, in a non-plasma environment. The particular process conditions may vary depending on the implementation. In these embodiments, the substrate may be exposed to the pretreatment chemistry in the presence energy from another energy source, including a thermal energy source, a ultra-violet source, a microwave source, etc. In certain embodiments, in addition to or instead of the pretreatment operations described above, a substrate is pretreated with exposure to a catalyst, surfactant, or adhesion-promoting chemical. The pre-treatment operation, if performed, may occur in the deposition chamber or may occur in another chamber prior to transfer of the substrate to the deposition chamber. Once in the deposition chamber, and after the optional pre-treatment operation, process gases are introduced.


Surface treatments to create hydrophilic surfaces that can be wet and nucleate evenly during deposition are described in U.S. patent application Ser. No. 14/519,400, titled “Treatment For Flowable Dielectric Deposition On Substrate Surfaces,” incorporated by reference herein. As described therein, the surface treatments may involve exposure to a remote plasma.


Experimental


FIG. 7 shows an image 701 of uniform densified flowable film formed with in-situ UV exposure as described with reference to FIG. 4A. TVTMCTS was the dielectric precursor, with no oxidant employed. Chamber pressure was 25 Torr and substrate temperature was 25° C. A 12 KW UV source at 35% power (4.2 KW) was used to irradiate the chamber interior during deposition. Notably the film is of uniform density (indicated by the uniform shade of the fill in the image) and there is no line bending observed. This indicates that the flowability of the film is maintained without line bending. The results shown in image 701 are substantially better than those deposited using triethoxysilane (TES) as shown in images 703, 705 and 707, regardless of the cure. The flowable oxide in image 703 was exposed to a UV Cure at 250° C.; the flowable oxide in image 705 was exposed to a thermal cure at 545° C. for 10 minutes, and the flowable oxide in image 707 was exposed to a thermal cure at 545° C. for 10 minutes followed by a UV cure. In each case, there is a density gradient (visible by the graded, non-uniform shade in the images) indicated in the circled portion.



FIG. 8 shows Fourier transform infrared spectroscopy (FTIR) spectra for films deposited from TVTMCTS with no oxidant employed and in-situ UV exposure during the deposition. The spectra show that the deposited films retain Si—CH3 groups. Cage and network oxide phases are observed. Residual vinyl groups are observed in thicker films.


Apparatus


The methods of the present invention may be performed on a wide-range of modules. The methods may be implemented on any apparatus equipped for deposition of dielectric film, including HDP-CVD reactors, PECVD reactors, sub-atmospheric CVD reactors, any chamber equipped for CVD reactions, and chambers used for PDL (pulsed deposition layers).


Such an apparatus may take many different forms. Generally, the apparatus will include one or more modules, with each module including a chamber or reactor (sometimes including multiple stations) that house one or more wafers and are suitable for wafer processing. Each chamber may house one or more wafers for processing. The one or more chambers maintain the wafer in a defined position or positions (with or without motion within that position, e.g. rotation, vibration, or other agitation). While in process, each wafer is held in place by a pedestal, wafer chuck and/or other wafer holding apparatus. For certain operations in which the wafer is to be heated, the apparatus may include a heater such as a heating plate. Examples of suitable reactors are the Sequel™ reactor, the Vector™, the Speed™ reactor, and the Gamma™ reactor all available from Lam Research of Fremont, Calif.


As discussed above, according to various embodiments, the surface treatment may take place in the same or different module as the flowable dielectric deposition. FIG. 9 shows an example tool configuration 960 including wafer transfer system 995 and loadlocks 990, flowable deposition module 970, and UV module 980. Additional modules, such as a pre-deposition treatment module, and/or one or more additional deposition modules 970 or UV modules 980 may also be included at 975.


Modules that may be used for pre-treatment include SPEED or SPEED Max, INOVA Reactive Preclean Module (RPM), Altus ExtremeFill (EFx) Module, Vector Extreme Pre-treatment Module (for plasma, ultra-violet or infra-red pre-treatment), and Vector or Vector Extreme modules. A SOLA module may be used for UV exposure. All of the tools are available from Lam Research, Fremont Calif. These modules may be attached to the same backbone as the flowable deposition module. Also, any of these modules may be on different backbones. A controller may be connected to any or all of the components of a tool; its placement and connectivity may vary based on the particular implementation.


In certain embodiments, a controller 922 is employed to control process conditions during deposition and/or pre or post-treatment. Further description of a controller is provided below.



FIG. 10 shows an example of a deposition chamber for flowable dielectric deposition. A deposition chamber 1000 (also referred to as a reactor, or reactor chamber) includes chamber housing 1002, top plate 1004, skirt 1006, showerhead 1008, pedestal column 1024, and seal 1026 provide a sealed volume for flowable dielectric deposition. Wafer 1010 is supported by chuck 1012 and insulating ring 1014. Chuck 1012 includes RF electrode 1016 and resistive heater element 1018. Chuck 1012 and insulating ring 1014 are supported by pedestal 1020, which includes platen 1022 and pedestal column 1024. Pedestal column 1024 passes through seal 1026 to interface with a pedestal drive (not shown). Pedestal column 1024 includes platen coolant line 1028 and pedestal purge line 1030. Showerhead 1008 includes co-reactant-plenum 1032 and precursor-plenum 1034, which are fed by co-reactant-gas line 1036 and precursor-gas line 1038, respectively. Co-reactant-gas line 1036 and precursor-gas line 1038 may be heated prior to reaching showerhead 1008 in zone 1040. While a dual-flow plenum is described herein, a single-flow plenum may be used to direct gas into the chamber. For example, reactants may be supplied to the showerhead and may mix within a single plenum before introduction into the reactor. 1020′ and 1020 refer to the pedestal, but in a lowered (1020) and raised (1020′) position.


The chamber is equipped with, or connected to, gas delivery system for delivering reactants to reactor chamber 1000. A gas delivery system may supply chamber 1010 with one or more co-reactants, such as oxidants, including water, oxygen, ozone, peroxides, alcohols, etc. which may be supplied alone or mixed with an inert carrier gas. The gas delivery system may also supply chamber with one or more dielectric precursors, for example triethoxysilane (TES), which may be supplied alone or mixed with an inert carrier gas. The gas delivery system is also configured to deliver one or more treatment reagents, for plasma treatment as described herein reactor cleaning. For example, for plasma processing, hydrogen, argon, nitrogen, oxygen or other gas may be delivered.


Deposition chamber 1000 serves as a sealed environment within which flowable dielectric deposition may occur. In many embodiments, deposition chamber 1000 features a radially symmetric interior. Reducing or eliminating departures from a radially symmetric interior helps ensure that flow of the reactants occurs in a radially balanced manner over wafer 1010. Disturbances to the reactant flows caused by radial asymmetries may cause more or less deposition on some areas of wafer 1010 than on other areas, which may produce unwanted variations in wafer uniformity.


Deposition chamber 1000 includes several main components. Structurally, deposition chamber 1000 may include a chamber housing 1002 and a top plate 1004. Top plate 1004 is configured to attach to chamber housing 1002 and provide a seal interface between chamber housing 1002 and a gas distribution manifold/showerhead, electrode, or other module equipment. Different top plates 1004 may be used with the same chamber housing 1002 depending on the particular equipment needs of a process.


Chamber housing 1002 and top plate 1004 may be machined from an aluminum, such as 6061-T6, although other materials may also be used, including other grades of aluminum, aluminum oxide, and other, non-aluminum materials. The use of aluminum allows for easy machining and handling and makes available the elevated heat conduction properties of aluminum.


Top plate 1004 may be equipped with a resistive heating blanket to maintain top plate 1004 at a desired temperature. For example, top plate 1004 may be equipped with a resistive heating blanket configured to maintain top plate 1004 at a temperature of between −20° C. and 100° C. Alternative heating sources may be used in addition to or as an alternative to a resistive heating blanket, such as circulating heated liquid through top plate 1004 or supplying top plate 1004 with a resistive heater cartridge.


Chamber housing 1002 may be equipped with resistive heater cartridges configured to maintain chamber housing 1002 at a desired temperature. Other temperature control systems may also be used, such as circulating heated fluids through bores in the chamber walls.


The chamber interior walls may be temperature-controlled during flowable dielectric to a temperature between −20° C. and 100° C. In some implementations, top plate 1004 may not include heating elements and may instead rely on thermal conduction of heat from chamber resistive heater cartridges to maintain a desired temperature. Various embodiments may be configured to temperature-control the chamber interior walls and other surfaces on which deposition is undesired, such as the pedestal, skirt, and showerhead, to a temperature approximately 10° C. to 40° C. higher than the target deposition process temperature. In some implementations, these components may be held at temperatures above this range.


Through actively heating and maintaining deposition chamber 1000 temperature during processing, the interior reactor walls may be kept at an elevated temperature with respect to the temperature at which wafer 1010 is maintained. Elevating the interior reactor wall temperature with respect to the wafer temperature may minimize condensation of the reactants on the interior walls of deposition chamber 1000 during flowable film deposition. If condensation of the reactants occurs on the interior walls of deposition chamber 1000, the condensate may form a deposition layer on the interior walls, which is undesirable.


In addition to, or alternatively to, heating chamber housing 1002 and/or top plate 1004, a hydrophobic coating may be applied to some or all of the wetted surfaces of deposition chamber 1000 and other components with wetted surfaces, such as pedestal 1020, insulating ring 1014, or platen 1022, to prevent condensation. Such a hydrophobic coating may be resistant to process chemistry and processing temperature ranges, e.g., a processing temperature range of −20° C. to 100° C. Some silicone-based and fluorocarbon-based hydrophobic coatings, such as polyethylene, may not be compatible with an oxidizing, e.g., plasma, environment and may not be suitable for use. Nano-technology based coatings with super-hydrophobic properties may be used; such coatings may be ultra-thin and may also possess oleophobic properties in addition to hydrophobic properties, which may allow such a coating to prevent condensation as well as deposition of many reactants, used in flowable film deposition. One example of a suitable super-hydrophobic coating is titanium dioxide (TiO2).


Various thermal breaks may separate various components of the chamber 1000. As used herein, a thermal break refers to a physical separation, i.e., gap, between parts which is sufficiently large enough to substantially prevent conductive heat transfer between the parts via any gases trapped within the thermal break yet which is also sufficiently small enough to prevent substantial convective heat transfer between the parts via the gases. Parts or portions of parts which are either in direct contact, or which are separated by a gap but which are still sufficiently close enough together to experience significant conductive heat transfer across the gap via any gases trapped within the gap, may be referred to as being in “thermal contact” with each other. Thermal breaks are described more fully in U.S. patent application Ser. No. 13/329,078, incorporated by reference herein.


Deposition chamber 1000 may also include one or more UV sources, which may be used for in situ UV exposure. This is discussed further below with respect to FIG. 12.



FIGS. 11A and 11B show an example of a UV chamber for UV exposure of flowable dielectric material. Chamber 1101 includes multiple stations 1103, 1105, 1107 and 1109, each of which can accommodate a substrate. Station 1103 includes transfer pins 1119. FIG. 11B is a side view of the chamber showing stations 1103 and 1105 and substrates 1113 and 1115 located above pedestals 1123 and 1125. There are gaps 1104 between the substrates and the pedestals. A substrate may be supported above a pedestal by an attachment, such as a pin, or floated on gas. Parabolic or planar cold mirrors 1153 and 1155 are located above UV flood lamp sets 1133 and 1135. UV light from lamp sets 1133 and 1135 passes through windows 1143 and 1145. Substrates 1103 and 1105 are then exposed to the radiation. In alternative embodiments, a substrate may be supported by the pedestals 1123 and 1125. The lamps may or may not be equipped with cold mirrors. In some embodiments, the substrate temperature may be maintained by use of a conductive gas such as helium or a mixture of helium and argon at a sufficiently high pressure, typically between 50 and 760 Torr.


In operation, a substrate may be sequentially exposed to each UV light source, with multiple substrates exposed to a UV light source in parallel. Alternatively, each substrate may be exposed to only one or subset of the UV light sources.


In some cases, different stations irradiate the wafer at different wavelengths or wavelengths ranges. The example above uses a UV flood lamp, which generates radiation in a broad spectrum. Optical components may be used in the radiation source to modulate the part of the broad spectrum that reaches the wafer. For example, reflectors, filters, or combination of both reflectors and filters may be used to subtract a part of the spectrum from the radiation. One such filter is a bandpass filter.


Optical bandpass filters are designed to transmit a specific waveband. They are composed of many thin layers of dielectric materials, which have differing refractive indices to produce constructive and destructive interference in the transmitted light. In this way optical bandpass filters can be designed to transmit a specific waveband only. The range limitations are usually dependent upon the interference filters lens, and the composition of the thin-film filter material. Incident light is passed through two coated reflecting surfaces. The distance between the reflective coatings determines which wavelengths will destructively interfere and which wavelengths will be allowed to pass through the coated surfaces. In situations where the reflected beams are in phase, the light will pass through the two reflective surfaces. However, if the wavelengths are out of phase, destructive interference will block most of the reflections, allowing almost nothing to transmit through. In this way, interference filters are able to attenuate the intensity of transmitted light at wavelengths that are higher or lower than the desired range.


Another filter that can attenuate the wavelengths of the radiation reaching the wafer is the window 343, typically made of quartz. By changing the level of metal impurities and water content, the quartz window can be made to block radiations of undesired wavelengths. High-purity Silica Quartz with very little metal impurity is more transparent deeper into the ultraviolet. As an example, quartz with a thickness of 1 cm will have a transmittance of about 50% at a wavelength of 170 nm, which drops to only a few percent at 160 nm. Increasing levels of impurities in the quartz cause transmission of UV at lower wavelengths to be reduced. Electrically fused quartz has a greater presence of metallic impurities, limiting its UV transmittance wavelength to around 200 nm. Synthetic silica, on the other hand, has much greater purity and will transfer down to 170 nm. For infrared radiation, the transmittance through quartz is determined by the water content. More water in the quartz means that infrared radiation is more likely absorbed. The water content in the quartz may be controlled through the manufacturing process. Thus, the spectrum of radiation transmission through the quartz window may be controlled to cutoff or reduce UV transmission at shorter wavelengths and/or to reduce infrared transmission at longer wavelengths.


Another type of filter is UV cut-off filters. These filters do not allow UV transmission below a set value, e.g. 280 nm. These filters work by absorbing wavelengths below the cut-off value. This may be helpful to optimize the desired cure effect.


Radiation wavelength can also be controlled by modifying the properties of the light generator. UV flood lamps can generate a broad spectrum of radiation, from UV to infrared, but other light generators may be used to emit a smaller spectrum or to increase the intensity of a narrower spectrum. Other light generators may be mercury-vapor lamps, doped mercury-vapor lamps, electrode lamps, excimer lamps, excimer lasers, pulsed Xenon lamps, doped Xenon lamps. Lasers such as excimer lasers can emit radiation of a single wavelength. When dopants are added to mercury-vapor and to Xenon lamps, radiation in a narrow wavelength band may be made more intense. Common dopants are iron, nickel, cobalt, tin, zinc, indium, gallium, thallium, antimony, bismuth, or combinations of these. For example, mercury vapor lamps doped with indium emits strongly in the visible spectrum and around 450 nm; iron, at 360 nm; and gallium, at 320 nm. Radiation wavelengths can also be controlled by changing the fill pressure of the lamps. For example, high-pressure mercury vapor lamps can be made to emit wavelengths of 250 to 440 nm, particularly 310 to 350 nm more intensely. Low-pressure mercury vapor lamps emit at shorter wavelengths.


In addition to changing light generator properties and the use of filters, reflectors that preferentially deliver one or more segments of the lamps spectral output may be used. A common reflector is a cold mirror that allows infrared radiation to pass but reflects other light. Other reflectors that preferentially reflect light of a spectral band may be used. Therefore a wafer may be exposed to radiation of different wavelengths at different stations. Of course, the radiation wavelengths may be the same in some stations.


In FIG. 11B, pedestals 1123 and 1125 are stationary. Indexer 1111 lifts and moves each substrate from one pedestal to another between each exposure period. Indexer 1111 is an indexer plate 1121 attached to a motion mechanism 1131 that has rotational and axial motion. Upward axial motion is imparted to indexer plate 1121 to pick up substrates from each pedestal. The rotational motion serves to advance the substrates from one station to another. The motion mechanism then imparts downward axial motion to the plate to put the substrates down on the stations.


Pedestals 1123 and 1125 may be electrically heated and maintained at a desired process temperature. As noted above, the substrate temperature is maintained at below the boiling point of the dielectric precursors in some embodiments. As such, pedestals 1123 and 1125 may also be equipped with cooling lines. Each pedestal may have its own heating or cooling system. In an alternate embodiment, a large heater block may be used to support the wafers instead of individual pedestals. A thermally conductive gas, such as helium, is used to cause good thermal coupling between the pedestal and the wafer. In some embodiments, cast pedestals with coaxial heat exchangers may be used. These are described in U.S. Pat. No. 7,327,948, incorporated by reference herein.



FIGS. 11A and 11B show only an example of a suitable apparatus and other apparatuses may be used. For example, in another embodiment that uses flood lamps, the substrate support may be a carousel. Unlike with the stationary pedestal substrate supports, the substrates do not move relative to the carousel. After a substrate is loaded onto the carousel, the carousel rotates, if necessary, to expose the wafer to light from a UV lamp set. The carousel is stationary during the exposure period. After the exposure period, the carousel may be rotated advance each substrate for exposure to the next set of lamps. Heating and cooling elements may be embedded within the rotating carousel. Alternatively the carousel may be in contact with a heat transfer plate or hold the substrates so that they are suspended above a heat transfer plate.


In certain embodiments, the substrates are exposed to UV radiation from focused, rather than, flood lamps. Unlike the flood lamp embodiments wherein the substrates are stationary during exposure (as in FIGS. 11A and 11B), there is relative movement between the wafers and the light sources during exposure to the focused lights as the substrates are scanned.



FIGS. 11A and 11B show an example of multi-station UV exposure tool that may be connected under vacuum to a flowable dielectric deposition tool to permit transfer between a flowable dielectric deposition tool and UV exposure tool under controlled pressure and temperature. An example of a multi-station UV exposure tool is the SOLA tool available from Lam Research of Fremont, Calif. Single station UV exposure tools may be employed.


In certain embodiments, a multi-station tool may be employed in which dielectric deposition occurs at a first station or subset of stations and UV exposure at a second station or subset of stations. A schematic example of such an apparatus is provided in FIG. 12A, which a multi-station chamber 1200 including a deposition station 1202 configured for cold condensation of a dielectric precursor or product thereof and UV station 1204 configured for UV exposure. One or more deposition stations 1202 may be configured as in the example of FIG. 10. One or more UV exposure stations 1204 may be configured as station 1103 in the example of FIG. 11B.


One or more of the apparatuses depicted in FIGS. 9-12A may be used in to perform ex-situ UV exposure as discussed above with respect to FIG. 4A. To perform in-situ UV exposure, a UV exposure tool as shown in FIGS. 11A and 11B may be employed, with deposition gases inlet to the chamber, e.g., through side or top gas inlets. In alternate embodiments, a deposition chamber such as that shown in FIG. 10 may be equipped with one or more UV sources. A schematic example of such a chamber is shown in FIG. 12B. Chamber 1201 includes a showerhead 1203; similar to showerhead 1008 in the example of FIG. 10, showerhead 1203 has one or more plenums 1205 for introducing reactant gases to form a flowable film. Further, UV sources 1207 are embedded within or mounted on the showerhead to provide UV radiation. Each UV source 1207 may be separated from the interior of the chamber 1201 by a window 1209. Examples of windows are described above with reference to FIGS. 11A and 11B. The showerhead 1203 may be designed such that the UV sources 1207 and gas openings are in a regular pattern such that gas delivery and UV irradiation are fairly uniform across a substrate in the chamber. For example, the UV sources and/or the showerhead holes may be in a hexagonal pattern. FIG. 12 also shows a purge gas 1211, e.g., Ar, that may be employed to keep the windows 1209 clean. A pedestal 1213 is configured to support a substrate. In some embodiments, the pedestal 1213, or a support thereon, is rotatable such that a substrate can be rotated if necessary during deposition to promote deposition and UV exposure uniformity.


As indicated above with respect to FIG. 9, in certain embodiments, a controller 922 is employed to control process conditions during deposition and/or pre or post-treatment. Such a controller may be used to control operations in any of the apparatuses depicted in FIGS. 9-12B.


The controller 922 will typically include one or more memory devices and one or more processors. The processor may include a CPU or computer, analog and/or digital input/output connections, stepper motor controller boards, etc. Typically there will be a user interface associated with controller 922. The user interface may include a display screen, graphical software displays of the apparatus and/or process conditions, and user input devices such as pointing devices, keyboards, touch screens, microphones, etc.


In certain embodiments, the controller 922 may also control all of the activities during the process, including gas flow rate, chamber pressure, generator process parameters. The controller 922 executes system control software including sets of instructions for controlling the timing, mixture of gases, chamber pressure, pedestal (and substrate) temperature, UV power, and other parameters of a particular process. The controller 922 may also control concentration of various process gases in the chamber by regulating valves, liquid delivery controllers and MFCs in the delivery system as well as flow restriction valves and the exhaust line. The controller 922 executes system control software including sets of instructions for controlling the timing, flow rates of gases and liquids, chamber pressure, substrate temperature, UV power, and other parameters of a particular process. Other computer programs stored on memory devices associated with the controller may be employed in some embodiments. In certain embodiments, the controller 922 controls the transfer of a substrate into and out of various components of the apparatuses.


The computer program code for controlling the processes in a process sequence can be written in any conventional computer readable programming language: for example, assembly language, C, C++, Pascal, Fortran or others. Compiled object code or script is executed by the processor to perform the tasks identified in the program. The system software may be designed or configured in many different ways. For example, various chamber component subroutines or control objects may be written to control operation of the chamber components necessary to carry out the described processes. Examples of programs or sections of programs for this purpose include process gas control code and pressure control code.


In some implementations, the controller 922 is part of a system, which may be part of the above-described examples. Such systems can include semiconductor processing equipment, including a processing tool or tools, chamber or chambers, a platform or platforms for processing, and/or specific processing components (a wafer pedestal, a gas flow system, etc.). These systems may be integrated with electronics for controlling their operation before, during, and after processing of a semiconductor wafer or substrate. The electronics may be referred to as the “controller,” which may control various components or subparts of the system or systems. The controller 922, depending on the processing requirements and/or the type of system, may be programmed to control any of the processes disclosed herein, including the delivery of processing gases, temperature settings (e.g., heating and/or cooling), pressure settings, vacuum settings, power settings, radio frequency (RF) generator settings, RF matching circuit settings, frequency settings, flow rate settings, fluid delivery settings, UV power and duty cycle settings, positional and operation settings, wafer transfers into and out of a tool and other transfer tools and/or load locks connected to or interfaced with a specific system.


Broadly speaking, the controller 922 may be defined as electronics having various integrated circuits, logic, memory, and/or software that receive instructions, issue instructions, control operation, enable cleaning operations, enable endpoint measurements, and the like. The integrated circuits may include chips in the form of firmware that store program instructions, digital signal processors (DSPs), chips defined as application specific integrated circuits (ASICs), and/or one or more microprocessors, or microcontrollers that execute program instructions (e.g., software). Program instructions may be instructions communicated to the controller 922 in the form of various individual settings (or program files), defining operational parameters for carrying out a particular process on or for a semiconductor wafer or to a system. The operational parameters may, in some embodiments, be part of a recipe defined by process engineers to accomplish one or more processing steps during the fabrication of one or more layers, materials, metals, oxides, silicon, silicon dioxide, surfaces, circuits, and/or dies of a wafer.


The controller 922, in some implementations, may be a part of or coupled to a computer that is integrated with, coupled to the system, otherwise networked to the system, or a combination thereof. For example, the controller 922 may be in the “cloud” or all or a part of a fab host computer system, which can allow for remote access of the wafer processing. The computer may enable remote access to the system to monitor current progress of fabrication operations, examine a history of past fabrication operations, examine trends or performance metrics from a plurality of fabrication operations, to change parameters of current processing, to set processing steps to follow a current processing, or to start a new process. In some examples, a remote computer (e.g. a server) can provide process recipes to a system over a network, which may include a local network or the Internet. The remote computer may include a user interface that enables entry or programming of parameters and/or settings, which are then communicated to the system from the remote computer. In some examples, the controller 922 receives instructions in the form of data, which specify parameters for each of the processing steps to be performed during one or more operations. It should be understood that the parameters may be specific to the type of process to be performed and the type of tool that the controller 922 is configured to interface with or control. Thus as described above, the controller 922 may be distributed, such as by comprising one or more discrete controllers that are networked together and working towards a common purpose, such as the processes and controls described herein. An example of a distributed controller for such purposes would be one or more integrated circuits on a chamber in communication with one or more integrated circuits located remotely (such as at the platform level or as part of a remote computer) that combine to control a process on the chamber.


Without limitation, example systems may include a plasma etch chamber or module, a deposition chamber or module, a spin-rinse chamber or module, a metal plating chamber or module, a clean chamber or module, a bevel edge etch chamber or module, a physical vapor deposition (PVD) chamber or module, a chemical vapor deposition (CVD) chamber or module, an atomic layer deposition (ALD) chamber or module, an atomic layer etch (ALE) chamber or module, an ion implantation chamber or module, a track chamber or module, a UV exposure chamber or module, and any other semiconductor processing systems that may be associated or used in the fabrication and/or manufacturing of semiconductor wafers.


As noted above, depending on the process step or steps to be performed by the tool, the controller 922 might communicate with one or more of other tool circuits or modules, other tool components, cluster tools, other tool interfaces, adjacent tools, neighboring tools, tools located throughout a factory, a main computer, another controller, or tools used in material transport that bring containers of wafers to and from tool locations and/or load ports in a semiconductor manufacturing factory.


The controller parameters relate to process conditions such as, for example, timing of each operation, pressure inside the chamber, substrate temperature, and process gas flow rates. These parameters are provided to the user in the form of a recipe, and may be entered utilizing the user interface. Signals for monitoring the process may be provided by analog and/or digital input connections of the controller 922. The signals for controlling the process are output on the analog and digital output connections of the apparatus.


The disclosed methods and apparatuses may also be implemented in systems including lithography and/or patterning hardware for semiconductor fabrication. Further, the disclosed methods may be implemented in a process with lithography and/or patterning processes preceding or following the disclosed methods. The apparatus/process described hereinabove may be used in conjunction with lithographic patterning tools or processes, for example, for the fabrication or manufacture of semiconductor devices, displays, LEDs, photovoltaic panels and the like. Typically, though not necessarily, such tools/processes will be used or includes together in a common fabrication facility. Lithographic patterning of a film typically comprises some or all of the following steps, each step enabled with a number of possible tools: (1) application of photoresist on a workpiece, i.e., substrate, using a spin-on or spray-on tool; (2) curing of photoresist using a hot plate or furnace or UV curing tool; (3) exposing the photoresist to visible or UV or x-ray light with a tool such as a wafer stepper; (4) developing the resist so as to selectively remove resist and thereby pattern it using a tool such as a wet bench; (5) transferring the resist pattern into an underlying film or workpiece by using a dry or plasma-assisted etching tool; and (6) removing the resist using a tool such as an RF or microwave plasma resist stripper.


Although the foregoing invention has been described in some detail for purposes of clarity of understanding, it will be apparent that certain changes and modifications may be practiced within the scope of the appended claims. It should be noted that there are many alternative ways of implementing the processes, systems and apparatus of the present invention. Accordingly, the present embodiments are to be considered as illustrative and not restrictive, and the invention is not to be limited to the details given herein.

Claims
  • 1. An apparatus comprising: a chamber including chamber walls and a substrate support;a ultraviolet radiation source;a showerhead configured to distribute a reactant to the chamber; anda controller comprising machine readable instructions for:concurrently performing:introducing a vapor silicon precursor to the chamber via the showerhead at a substrate support temperature less than the silicon precursor to thereby form a flowable film on a substrate supported by the substrate support;powering the ultraviolet radiation source to expose the flowable film to UV radiation; andmaintaining the substrate support at a temperature less than the boiling point of the silicon precursor during the exposure.
  • 2. The apparatus of claim 1, wherein the chamber is a single-station chamber.
  • 3. The apparatus of claim 1, wherein the chamber is a multi-station chamber.
  • 4. The apparatus of claim 1, wherein the ultraviolet radiation source is embedded within or mounted to the showerhead.
  • 5. The apparatus of claim 4, further comprising a plurality of ultraviolet radiation sources evenly distributed across the showerhead.
  • 6. The apparatus of claim 4, wherein the substrate support is rotatable.
  • 7. The apparatus of claim 6, wherein the controller further comprises machine readable instructions for rotating the substrate support during exposure of the flowable film to UV radiation.
  • 8. The apparatus of claim 1, wherein the ultraviolet radiation source is part of a second chamber connected to the chamber.
  • 9. The apparatus of claim 1, wherein the controller further comprises machine readable instructions for maintaining the chamber walls at a temperature 10° C. to 40° C. higher than the substrate support temperature.
  • 10. A method comprising: introducing a vapor phase silicon precursor to a first station of a multi-station chamber, the first station housing a substrate;condensing the silicon precursor to form a flowable dielectric film to fill a gap on the substrate;transferring the substrate to a second station of a multi-station chamber, and while the substrate is in the second station of the multi-station chamber, exposing the substrate to ultraviolet radiation to polymerize the condensed precursor and form a solid dielectric film, wherein the substrate temperature is maintained at a temperature less than the boiling point of the silicon precursor during the exposure.
  • 11. The method of claim 10, wherein the silicon precursor is a cyclic silazane or cyclic siloxane.
  • 12. The method of claim 11, wherein the silicon precursor is octamethylcyclotetrasiloxane, tetravinyltetramethylcyclotetrasiloxane, tetramethylcyclotetrasiloxane, pentamethylcyclopentasiloxane, or hexamethylcyclotrisiloxane.
US Referenced Citations (406)
Number Name Date Kind
3504181 Campbell et al. Mar 1970 A
3704219 McDowell Nov 1972 A
4099990 Brown et al. Jul 1978 A
4527620 Pedersen et al. Jul 1985 A
4563589 Scheffer Jan 1986 A
4654226 Jackson et al. Mar 1987 A
4740480 Ooka Apr 1988 A
4832777 Davis et al. May 1989 A
4872947 Wang et al. Oct 1989 A
4923720 Lee et al. May 1990 A
4927786 Nishida May 1990 A
4956582 Bourassa Sep 1990 A
5005519 Egermeier et al. Apr 1991 A
5049739 Okamoto Sep 1991 A
5150253 Watanuki et al. Sep 1992 A
5166101 Lee et al. Nov 1992 A
5174881 Iwasaki et al. Dec 1992 A
5178682 Tsukamoto et al. Jan 1993 A
5195045 Keane et al. Mar 1993 A
5240746 O'Connell Litteral Aug 1993 A
5281274 Yoder Jan 1994 A
5282121 Bomhorst et al. Jan 1994 A
5288684 Yamazaki et al. Feb 1994 A
5298939 Swanson et al. Mar 1994 A
5314538 Maeda et al. May 1994 A
5320983 Ouellet Jun 1994 A
5354715 Wang et al. Oct 1994 A
5382311 Ishikawa et al. Jan 1995 A
5387546 Maeda et al. Feb 1995 A
5407524 Patrick et al. Apr 1995 A
5413664 Yagi et al. May 1995 A
5426076 Moghadam et al. Jun 1995 A
5462603 Murakami Oct 1995 A
5516721 Galli et al. May 1996 A
5518959 Jang et al. May 1996 A
5525157 Hawkins et al. Jun 1996 A
5534731 Cheung Jul 1996 A
5552927 Wheatly et al. Sep 1996 A
5556549 Patrick et al. Sep 1996 A
5558717 Zhao et al. Sep 1996 A
5667592 Boitnott et al. Sep 1997 A
5674783 Jang et al. Oct 1997 A
5747381 Wu et al. May 1998 A
5753886 Iwamura et al. May 1998 A
5775808 Pan Jul 1998 A
5795448 Hurwitt et al. Aug 1998 A
5796074 Edelstein et al. Aug 1998 A
5807785 Ravi Sep 1998 A
5833290 Curelop et al. Nov 1998 A
5840631 Kubo et al. Nov 1998 A
5858880 Dobson et al. Jan 1999 A
5874367 Dobson Feb 1999 A
5879574 Sivaramakrishnan et al. Mar 1999 A
5899751 Chang et al. May 1999 A
5902127 Park May 1999 A
5903428 Grimard et al. May 1999 A
5911833 Denison et al. Jun 1999 A
5932289 Dobson et al. Aug 1999 A
5958510 Sivaramakrishnam Sep 1999 A
5962085 Hayashi et al. Oct 1999 A
5970383 Lee Oct 1999 A
5990013 Berenguer et al. Nov 1999 A
5994678 Zhao et al. Nov 1999 A
6001183 Gurary et al. Dec 1999 A
6013581 Wu et al. Jan 2000 A
6015503 Butterbaugh et al. Jan 2000 A
6035101 Sajoto et al. Mar 2000 A
6044329 Kidd Mar 2000 A
6054379 Yau et al. Apr 2000 A
6060384 Chen et al. May 2000 A
6072227 Yau et al. Jun 2000 A
6080965 Osawa Jun 2000 A
6114224 Ngo et al. Sep 2000 A
6114259 Sukharev et al. Sep 2000 A
6143063 Hayashi et al. Nov 2000 A
6143626 Yabu et al. Nov 2000 A
6207535 Lee et al. Mar 2001 B1
6218268 Xia et al. Apr 2001 B1
6232248 Shinriki et al. May 2001 B1
6235112 Satoh May 2001 B1
6235146 Kadotani et al. May 2001 B1
6239018 Liu et al. May 2001 B1
6242366 Beekman et al. Jun 2001 B1
6242717 Sanderson Jun 2001 B1
6244575 Vaartstra et al. Jun 2001 B1
6251759 Guo et al. Jun 2001 B1
6259061 Osawa Jul 2001 B1
6284050 Shi et al. Sep 2001 B1
6287989 Dobson Sep 2001 B1
6288493 Lee et al. Sep 2001 B1
6291800 Shirakawa et al. Sep 2001 B1
6300219 Doan et al. Oct 2001 B1
6309933 Li et al. Oct 2001 B1
6323123 Liu et al. Nov 2001 B1
6383951 Li May 2002 B1
6394797 Sugaya et al. May 2002 B1
6399213 Shiokawa Jun 2002 B2
6413583 Moghadam et al. Jul 2002 B1
6439244 Wu Aug 2002 B1
6448187 Yau et al. Sep 2002 B2
6467491 Sugiura et al. Oct 2002 B1
6475564 Carter et al. Nov 2002 B1
6475854 Narwanker et al. Nov 2002 B2
6497783 Suzuki et al. Dec 2002 B1
6519036 Hickman Feb 2003 B1
6524389 Katayama et al. Feb 2003 B1
6530380 Zhou et al. Mar 2003 B1
6544858 Beekman et al. Apr 2003 B1
6563092 Shrinivasan et al. May 2003 B1
6568346 Pu et al. May 2003 B2
6605955 Costello et al. Aug 2003 B1
6613695 Pomarede et al. Sep 2003 B2
6629012 Riley et al. Sep 2003 B1
6635586 Goo et al. Oct 2003 B2
6640840 MacNeil Nov 2003 B1
6653247 MacNeil Nov 2003 B2
6660663 Cheung et al. Dec 2003 B1
6703321 Geiger et al. Mar 2004 B2
6740853 Johnson et al. May 2004 B1
6743436 Lee Jun 2004 B1
6743736 Mardian et al. Jun 2004 B2
6756085 Waldfried et al. Jun 2004 B2
6787463 Mardian et al. Sep 2004 B2
6790737 Schneegans et al. Sep 2004 B2
6812135 Li et al. Nov 2004 B2
6821906 Wada et al. Nov 2004 B2
6828162 Halliyal et al. Dec 2004 B1
6846757 MacNeil Jan 2005 B2
6858195 Aronowitz et al. Feb 2005 B2
6900413 Ratliff et al. May 2005 B2
6902947 Chinn et al. Jun 2005 B2
6972262 Lee et al. Dec 2005 B2
6977014 Stevens et al. Dec 2005 B1
6984561 Herner et al. Jan 2006 B2
6995056 Lee et al. Feb 2006 B2
7018479 Goodwin Mar 2006 B2
7020238 Kantonen et al. Mar 2006 B1
7025831 Butterbaugh et al. Apr 2006 B1
7033945 Byun et al. Apr 2006 B2
7056560 Yim et al. Jun 2006 B2
7067819 Janik Jun 2006 B2
7071126 Johnston et al. Jul 2006 B2
7074690 Gauri et al. Jul 2006 B1
7074727 Hsu et al. Jul 2006 B2
7084505 Hamada et al. Aug 2006 B2
7087497 Yuan et al. Aug 2006 B2
7091453 Murayama et al. Aug 2006 B2
7094713 Niu et al. Aug 2006 B1
7097712 Yamazaki et al. Aug 2006 B1
7153783 Lu et al. Dec 2006 B2
7160813 Chen et al. Jan 2007 B1
7169256 Dhindsa et al. Jan 2007 B2
7176144 Wang et al. Feb 2007 B1
7211525 Shanker et al. May 2007 B1
7214630 Varadarajan et al. May 2007 B1
7235137 Kitayama et al. Jun 2007 B2
7238604 Kloster et al. Jul 2007 B2
7244672 Nguyen et al. Jul 2007 B2
7256111 Lopatin et al. Aug 2007 B2
7264676 Lai et al. Sep 2007 B2
7271112 Papasouliotis et al. Sep 2007 B1
7301148 Johnson Nov 2007 B2
7304302 Nunan et al. Dec 2007 B1
7311782 Strang et al. Dec 2007 B2
7327948 Shrinivasan et al. Feb 2008 B1
7332445 Lukas et al. Feb 2008 B2
7365000 Lee et al. Apr 2008 B2
7394067 Soltz et al. Jul 2008 B1
7453560 Miyake Nov 2008 B2
7480129 Brown et al. Jan 2009 B2
7498273 Mallick et al. Mar 2009 B2
7521378 Fucsko et al. Apr 2009 B2
7524735 Gauri et al. Apr 2009 B1
7575633 Romanin Aug 2009 B2
7582555 Lang et al. Sep 2009 B1
7585704 Belyansky et al. Sep 2009 B2
7589012 Seo et al. Sep 2009 B1
7622369 Lee et al. Nov 2009 B1
7629227 Wang et al. Dec 2009 B1
7638780 Kilburn et al. Dec 2009 B2
7642205 Timans Jan 2010 B2
7648927 Singh et al. Jan 2010 B2
7655532 Chen et al. Feb 2010 B1
7670436 Miller et al. Mar 2010 B2
7704894 Henry et al. Apr 2010 B1
7727906 Shanker et al. Jun 2010 B1
7772527 Choi Aug 2010 B2
7790243 Radhakrishnan et al. Sep 2010 B2
7794544 Nguyen et al. Sep 2010 B2
7804130 Fung Sep 2010 B1
7825044 Mallick et al. Nov 2010 B2
7888233 Gauri et al. Feb 2011 B1
7888273 Wang et al. Feb 2011 B1
7915139 Lang et al. Mar 2011 B1
7935940 Smargiassi May 2011 B1
7941039 Shrinivasan et al. May 2011 B1
7947551 Syue et al. May 2011 B1
7960297 Rivkin et al. Jun 2011 B1
7993937 Chen et al. Aug 2011 B2
7999356 Nakasaki et al. Aug 2011 B2
8058181 Chen et al. Nov 2011 B1
8075789 Littau et al. Dec 2011 B1
8137465 Shrinivasan et al. Mar 2012 B1
8178159 Baikerikar et al. May 2012 B2
8187951 Wang et al. May 2012 B1
8211510 Varadarajan et al. Jul 2012 B1
8246778 Lu et al. Aug 2012 B2
8278224 Mui et al. Oct 2012 B1
8282768 Smargiassi et al. Oct 2012 B1
8283644 Smargiassi et al. Oct 2012 B2
8398816 Gytri et al. Mar 2013 B1
8454750 Shrinivasan et al. Jun 2013 B1
8481403 Gauri et al. Jul 2013 B1
8512818 Varadarajan et al. Aug 2013 B1
8518210 Smargiassi et al. Aug 2013 B2
8557712 Antonelli et al. Oct 2013 B1
8580697 Lang et al. Nov 2013 B1
8608035 Lee et al. Dec 2013 B2
8629068 Shrinivasan et al. Jan 2014 B1
8664287 Shukla Mar 2014 B2
8685867 Danek et al. Apr 2014 B1
8728958 Ashtiani et al. May 2014 B2
8734663 Smargiassi et al. May 2014 B2
8809161 Gauri et al. Aug 2014 B2
8846536 Draeger et al. Sep 2014 B2
8883406 Lee et al. Nov 2014 B2
8889233 Kelman et al. Nov 2014 B1
8951348 Shrinivasan et al. Feb 2015 B1
8980769 Haverkamp et al. Mar 2015 B1
9028765 Gytri et al. May 2015 B2
9064684 Mui et al. Jun 2015 B1
9073100 Gytri et al. Jul 2015 B2
9224594 Kashefi et al. Dec 2015 B2
9245739 Ndiege et al. Jan 2016 B2
9257302 Wang et al. Feb 2016 B1
9299559 Draeger et al. Mar 2016 B2
9384959 Smargiassi et al. Jul 2016 B2
9719169 Mohn et al. Aug 2017 B2
9847222 Reilly et al. Dec 2017 B2
9916977 Van Cleemput Mar 2018 B2
10020197 Gytri et al. Jul 2018 B2
10049921 Draeger et al. Aug 2018 B2
10121682 Smargiassi et al. Nov 2018 B2
10388546 Mohn Aug 2019 B2
20010018267 Shinriki et al. Aug 2001 A1
20010054381 Umotoy et al. Dec 2001 A1
20020006729 Geiger et al. Jan 2002 A1
20020007785 Gujer et al. Jan 2002 A1
20020017242 Hamaguchi et al. Feb 2002 A1
20020050246 Parkhe May 2002 A1
20020066726 Cole et al. Jun 2002 A1
20020076490 Chiang et al. Jun 2002 A1
20020098627 Pomarede et al. Jul 2002 A1
20020117109 Hazelton et al. Aug 2002 A1
20020134439 Kawasaki et al. Sep 2002 A1
20020148563 Carlson et al. Oct 2002 A1
20020170484 Katamine et al. Nov 2002 A1
20030007917 Ohmi et al. Jan 2003 A1
20030013280 Yamanaka Jan 2003 A1
20030015669 Janos et al. Jan 2003 A1
20030040199 Agarwal Feb 2003 A1
20030066482 Pokharna et al. Apr 2003 A1
20030077887 Jang et al. Apr 2003 A1
20030121898 Kane et al. Jul 2003 A1
20030124870 Macneil et al. Jul 2003 A1
20030146416 Takei et al. Aug 2003 A1
20030150560 Kinnard et al. Aug 2003 A1
20030159655 Lin et al. Aug 2003 A1
20030194493 Chang et al. Oct 2003 A1
20030194861 Mardian et al. Oct 2003 A1
20030199603 Walker et al. Oct 2003 A1
20030200931 Goodwin Oct 2003 A1
20030207580 Li et al. Nov 2003 A1
20030210065 Lu et al. Nov 2003 A1
20040023513 Aoyama et al. Feb 2004 A1
20040025787 Selbrede et al. Feb 2004 A1
20040033639 Chinn et al. Feb 2004 A1
20040048455 Karasawa et al. Mar 2004 A1
20040082163 Mori et al. Apr 2004 A1
20040096593 Lukas et al. May 2004 A1
20040152342 Li et al. Aug 2004 A1
20040169005 Kim et al. Sep 2004 A1
20040221871 Fletcher et al. Nov 2004 A1
20040224496 Cui et al. Nov 2004 A1
20040266214 Suguro et al. Dec 2004 A1
20050006916 Mantz Jan 2005 A1
20050016687 Shinriki et al. Jan 2005 A1
20050020074 Kloster et al. Jan 2005 A1
20050020093 Ahn et al. Jan 2005 A1
20050026443 Goo et al. Feb 2005 A1
20050056369 Lai et al. Mar 2005 A1
20050064698 Chang et al. Mar 2005 A1
20050072716 Quiles et al. Apr 2005 A1
20050085094 Yoo Apr 2005 A1
20050098553 Devine et al. May 2005 A1
20050109276 Iyer et al. May 2005 A1
20050112282 Gordon May 2005 A1
20050136684 Mukai et al. Jun 2005 A1
20050150453 Simmons et al. Jul 2005 A1
20050181566 Machida et al. Aug 2005 A1
20050190248 Konno et al. Sep 2005 A1
20050191863 Olmer et al. Sep 2005 A1
20050196929 Yuan et al. Sep 2005 A1
20050212179 Honda et al. Sep 2005 A1
20050229849 Silvetti et al. Oct 2005 A1
20050255712 Kato et al. Nov 2005 A1
20050258542 Fuller et al. Nov 2005 A1
20050260864 Huang et al. Nov 2005 A1
20050263719 Ohdaira et al. Dec 2005 A1
20050264218 Dhindsa et al. Dec 2005 A1
20060014384 Lee et al. Jan 2006 A1
20060021568 Matsumoto Feb 2006 A1
20060024912 Lee Feb 2006 A1
20060074153 Boisseau et al. Apr 2006 A1
20060105106 Balseanu et al. May 2006 A1
20060141806 Waldfried et al. Jun 2006 A1
20060172531 Lin et al. Aug 2006 A1
20060172552 Ajmera et al. Aug 2006 A1
20060183345 Nguyen et al. Aug 2006 A1
20060216839 Shemesh et al. Sep 2006 A1
20060216946 Usami et al. Sep 2006 A1
20060223290 Belyansky et al. Oct 2006 A1
20060269693 Balseanu Nov 2006 A1
20060270217 Balseanu et al. Nov 2006 A1
20070034159 Komino et al. Feb 2007 A1
20070054505 Antonelli et al. Mar 2007 A1
20070134821 Thakur Jun 2007 A1
20070161230 Chen et al. Jul 2007 A1
20070196011 Cox et al. Aug 2007 A1
20070218204 Garg et al. Sep 2007 A1
20070224777 Hamelin Sep 2007 A1
20070235660 Hudson Oct 2007 A1
20070256785 Pamarthy et al. Nov 2007 A1
20070258186 Matyushkin et al. Nov 2007 A1
20070277734 Lubomirsky et al. Dec 2007 A1
20070281495 Mallick et al. Dec 2007 A1
20070289534 Lubomirsky Dec 2007 A1
20070296035 George et al. Dec 2007 A1
20070298585 Lubomirsky et al. Dec 2007 A1
20080020591 Balseanu et al. Jan 2008 A1
20080053615 Sago et al. Mar 2008 A1
20080054466 Nasu et al. Mar 2008 A1
20080066682 Yamashita Mar 2008 A1
20080081434 Nam et al. Apr 2008 A1
20080089001 Parkhe et al. Apr 2008 A1
20080132087 Xia et al. Jun 2008 A1
20080199977 Weigel et al. Aug 2008 A1
20080274626 Glowacki et al. Nov 2008 A1
20080286697 Verhaverbeke et al. Nov 2008 A1
20080295872 Riker et al. Dec 2008 A1
20080318439 Ito et al. Dec 2008 A1
20090020847 Byun et al. Jan 2009 A1
20090053895 Oshima et al. Feb 2009 A1
20090059406 Powers et al. Mar 2009 A1
20090061647 Mallick et al. Mar 2009 A1
20090104789 Mallick et al. Apr 2009 A1
20090104790 Liang Apr 2009 A1
20090159566 Brillhart et al. Jun 2009 A1
20090159587 Shimanuki et al. Jun 2009 A1
20090190908 Shibagaki Jul 2009 A1
20090215282 Moore et al. Aug 2009 A1
20090298257 Lee et al. Dec 2009 A1
20090321936 Kojima et al. Dec 2009 A1
20100000684 Choi Jan 2010 A1
20100055904 Chen et al. Mar 2010 A1
20100109155 Liu et al. May 2010 A1
20100167533 Lim et al. Jul 2010 A1
20100267231 Van Schravendijk et al. Oct 2010 A1
20110020955 DeYoung Jan 2011 A1
20110070665 Chen et al. Mar 2011 A1
20110081782 Liang et al. Apr 2011 A1
20110151678 Ashtiani et al. Jun 2011 A1
20110262870 Lee et al. Oct 2011 A1
20120091097 Chen et al. Apr 2012 A1
20120132618 Baluja May 2012 A1
20120149213 Nittala et al. Jun 2012 A1
20120161021 Smargiassi et al. Jun 2012 A1
20120161405 Mohn et al. Jun 2012 A1
20120164328 Kojima et al. Jun 2012 A1
20120213940 Mallick Aug 2012 A1
20130122718 Kato et al. May 2013 A1
20130160946 Smargiassi et al. Jun 2013 A1
20130230987 Draeger et al. Sep 2013 A1
20130284087 Gytri et al. Oct 2013 A1
20130298940 Smargiassi et al. Nov 2013 A1
20140004717 Chan et al. Jan 2014 A1
20140017904 Gauri et al. Jan 2014 A1
20140065557 Lee et al. Mar 2014 A1
20140080324 Shrinivasan et al. Mar 2014 A1
20140106083 Wu et al. Apr 2014 A1
20140150647 Ahn et al. Jun 2014 A1
20140230861 Smargiassi et al. Aug 2014 A1
20140302689 Ashtiani et al. Oct 2014 A1
20140329027 Liang Nov 2014 A1
20150004806 Ndiege et al. Jan 2015 A1
20150044882 Draeger et al. Feb 2015 A1
20150056108 Gytri et al. Feb 2015 A1
20150114292 Haverkamp et al. Apr 2015 A1
20150118862 Reilly et al. Apr 2015 A1
20150118863 Rathod et al. Apr 2015 A1
20150255285 Gytri et al. Sep 2015 A1
20160056071 Draeger et al. Feb 2016 A1
20160284574 Smargiassi et al. Sep 2016 A1
20170137943 Mohn et al. May 2017 A1
20170140931 Van Cleemput et al. May 2017 A1
20180315604 Gytri et al. Nov 2018 A1
Foreign Referenced Citations (48)
Number Date Country
1655330 Aug 2005 CN
1722403 Jan 2006 CN
1815709 Aug 2006 CN
101079391 Nov 2007 CN
102089861 Jun 2011 CN
102420164 Apr 2012 CN
0 063 692 Dec 2000 EP
0 819 780 Feb 2004 EP
63307740 Dec 1988 JP
01-107519 Apr 1989 JP
05-031735 Feb 1993 JP
05-138658 Jun 1993 JP
62-229833 Oct 1997 JP
11-214364 Aug 1999 JP
2001-104776 Apr 2001 JP
2001-148382 May 2001 JP
2002-508587 Mar 2002 JP
2004-307939 Nov 2004 JP
2006-003608 Jan 2006 JP
2007-194582 Aug 2007 JP
2008-008848 Jan 2008 JP
2010-153859 Jul 2010 JP
2010-219354 Sep 2010 JP
2000-0043888 Jul 2000 KR
10-2005-0119684 Dec 2005 KR
10-2006-0005476 Jan 2006 KR
10-2007-0104591 Oct 2007 KR
10-2008-0018946 Feb 2008 KR
10-0856473 Sep 2008 KR
10-2009-0040867 Apr 2009 KR
10-2010-0079154 Jul 2010 KR
2012-0089792 Aug 2012 KR
380286 Jan 2000 TW
200400589 Jan 2004 TW
200807510 Feb 2008 TW
200809927 Feb 2008 TW
200809965 Feb 2008 TW
201447019 Dec 2014 TW
WO 9922043 May 1999 WO
WO 0240740 May 2002 WO
WO 03021642 Mar 2003 WO
WO 2004105103 Dec 2004 WO
WO 2006104583 Oct 2006 WO
WO 2006127463 Nov 2006 WO
WO 2007001281 Jan 2007 WO
WO 2007140376 Dec 2007 WO
WO 2007140424 Dec 2007 WO
WO 2011072143 Jun 2011 WO
Non-Patent Literature Citations (204)
Entry
U.S. Office Action, dated Jan. 20, 2016, issued in U.S. Appl. No. 14/519,400.
U.S. Final Office Action, dated Jul. 29, 2016, issued in U.S. Appl. No. 14/519,400.
U.S. Office Action, dated Mar. 27, 2017, issued in U.S. Appl. No. 14/519,400.
U.S. Notice of Allowance, dated Aug. 15, 2017, issued in U.S. Appl. No. 14/519,400.
U.S. Office Action, dated Jan. 21, 2016, issued in U.S. Appl. No. 14/519,712.
U.S. Final Office Action, dated Jul. 29, 2016, issued in U.S. Appl. No. 14/519,712.
U.S. Office Action, dated May 4, 2017, issued in U.S. Appl. No. 14/519,712.
U.S. Office Action, dated Dec. 30, 2015, issued in U.S. Appl. No. 14/464,071.
U.S. Final Office Action, dated Sep. 2, 2016, issued in U.S. Appl. No. 14/464,071.
U.S. Office Action, dated May 11, 2017, issued in U.S. Appl. No. 14/464,071.
U.S. Final Office Action, dated Jan. 26, 2018, issued in U.S. Appl. No. 14/464,071.
U.S. Notice of Allowance dated Apr. 12, 2018, issued in U.S. Appl. No. 14/464,071.
U.S. Office Action, dated Mar. 25, 2015, issued in U.S. Appl. No. 14/464,196.
U.S. Notice of Allowance, dated Sep. 14, 2015, issued in U.S. Appl. No. 14/464,196.
U.S. Office Action, dated May 18, 2018, issued in U.S. Appl. No. 14/942,703.
U.S. Final Office Action, dated Dec. 21, 2018, issued in U.S. Appl. No. 14/942,703.
U.S. Notice of Allowance, dated Mar. 26, 2019, issued in U.S. Appl. No. 14/942,703.
U.S. Office Action, dated May 6, 2016, issued in U.S. Appl. No. 14/942,704.
U.S. Final Office Action, dated Oct. 19, 2016, issued in U.S. Appl. No. 14/942,704.
U.S. Notice of Allowance, dated Oct. 30, 2017, issued in U.S. Appl. No. 14/942,704.
U.S. Office Action, dated Aug. 23, 2005, issued in U.S. Appl. No. 10/810,066.
U.S. Notice of Allowance and Fee Due, dated Feb. 15, 2006, issued in U.S. Appl. No. 10/810,066.
U.S. Office Action, dated Jun. 27, 2008, issued in U.S. Appl. No. 11/447,594.
U.S. Notice of Allowance and Fee Due, dated Dec. 11, 2008, issued in U.S. Appl. No. 11/447,594.
U.S. Office Action, dated May 24, 2010, issued in U.S. Appl. No. 12/411,243.
U.S. Final Office Action, dated Sep. 13, 2010, issued in U.S. Appl. No. 12/411,243.
U.S. Notice of Allowance, dated Oct. 6, 2010, issued in U.S. Appl. No. 12/411,243.
U.S. Office Action, dated May 18, 2012, issued in U.S. Appl. No. 12/984,524.
U.S. Final Office Action, dated Sep. 14, 2012, issued in U.S. Appl. No. 12/984,524.
U.S. Notice of Allowance, dated Mar. 7, 2013, issued in U.S. Appl. No. 12/984,524.
U.S. Office Action, dated Dec. 16, 2013, issued in U.S. Appl. No. 13/935,398.
U.S. Notice of Allowance, dated Apr. 11, 2014, issued in U.S. Appl. No. 13/935,398.
U.S. Office Action, dated Oct. 26, 2007, issued in U.S. Appl. No. 11/323,812.
U.S. Final Office Action, dated Apr. 9, 2008, issued in U.S. Appl. No. 11/323,812.
U.S. Office Action, dated Oct. 9, 2008, issued in U.S. Appl. No. 11/323,812.
U.S. Notice of Allowance and Fee Due, dated Apr. 23, 2009, issued in U.S. Appl. No. 11/323,812.
U.S. Notice of Allowance, dated Nov. 18, 2010, issued in U.S. Appl. No. 12/508,461.
U.S. Notice of Allowance, dated Aug. 6, 2012, issued in U.S. Appl. No. 13/031,077.
U.S. Notice of Allowance, dated Jul. 8, 2013, issued in U.S. Appl. No. 13/031,077.
U.S. Office Action, dated Nov. 4, 2008, issued in U.S. Appl. No. 11/925,514.
U.S. Final Office Action, dated Jun. 17, 2009, issued in U.S. Appl. No. 11/925,514.
U.S. Notice of Allowance, dated Jul. 29, 2009, issued in U.S. Appl. No. 11/925,514.
U.S. Office Action, dated Apr. 26, 2011, issued in U.S. Appl. No. 12/625,468.
U.S. Final Office Action, dated Oct. 14, 2011, issued in U.S. Appl. No. 12/625,468.
U.S. Notice of Allowance, dated Jan. 31, 2012, issued in U.S. Appl. No. 12/625,468.
U.S. Office Action, dated Aug. 15, 2013, issued in U.S. Appl. No. 13/461,287.
U.S. Office Action, dated Feb. 28, 2014, issued in U.S. Appl. No. 13/461,287.
U.S. Final Office Action, dated Aug. 26, 2014, issued in U.S. Appl. No. 13/461,287.
U.S. Notice of Allowance, dated Apr. 20, 2015, issued in U.S. Appl. No. 13/461,287.
U.S. Notice of Allowance, dated Sep. 10, 2015, issued in U.S. Appl. No. 13/461,287.
U.S. Notice of Allowance [Corrected Notice of Allowability], dated Oct. 22, 2015, issued in U.S. Appl. No. 13/461,287.
U.S. Notice of Allowance [Corrected Notice of Allowability], dated Jan. 11, 2016, issued in U.S. Appl. No. 13/461,287.
U.S. Office Action, dated Nov. 12, 2008, issued in U.S. Appl. No. 11/834,581.
U.S. Final Office Action, dated Aug. 6, 2009, issued in U.S. Appl. No. 11/834,581.
U.S. Office Action dated Dec. 18, 2009, issued in U.S. Appl. No. 11/834,581.
U.S. Final Office Action, dated Apr. 22, 2010, issued in U.S. Appl. No. 11/834,581.
U.S. Notice of Allowance, dated Oct. 7, 2010, issued in U.S. Appl. No. 11/834,581.
U.S. Office Action, dated Feb. 26, 2010, issued in U.S. Appl. No. 12/334,726.
U.S. Final Office Action, dated Oct. 26, 2010, issued in U.S. Appl. No. 12/334,726.
U.S. Office Action, dated Sep. 16, 2011, issued in U.S. Appl. No. 12/334,726.
U.S. Final Office Action, dated Mar. 30, 2012, issued in U.S. Appl. No. 12/334,726.
U.S. Final Office Action, dated Oct. 23, 2012, issued in U.S. Appl. No. 12/334,726.
U.S. Notice of Allowance dated Jun. 10, 2013, issued in U.S. Appl. No. 12/334,726.
U.S. Notice of Allowance, dated May 29, 2012, issued in U.S. Appl. No. 12/566,085.
U.S. Notice of Allowance, dated Jun. 21, 2012, issued in U.S. Appl. No. 12/566,085.
U.S. Office Action, dated Jun. 21, 2013, issued in U.S. Appl. No. 13/607,511.
U.S. Final Office Action, dated Dec. 11, 2013, issued in U.S. Appl. No. 13/607,511.
U.S. Office Action, dated Jul. 25, 2014, issued in U.S. Appl. No. 13/607,511.
U.S. Notice of Allowance, dated Jan. 23, 2015, issued in U.S. Appl. No. 13/607,511.
U.S. Office Action, dated Dec. 21, 2012, issued in U.S. Appl. No. 12/964,110.
U.S. Final Office Action, dated Sep. 12, 2013, issued in U.S. Appl. No. 12/694,110.
U.S. Notice of Allowance, dated Dec. 27, 2013, issued in U.S. Appl. No. 12/964,110.
U.S. Notice of Allowance, dated Apr. 23, 2014, issued in U.S. Appl. No. 12/964,110.
U.S. Office Action, dated Jun. 24, 2016, issued in U.S. Appl. No. 14/249,272.
U.S. Office Action, dated Dec. 6, 2012, issued in U.S. Appl. No. 13/315,123.
U.S. Office Action, dated Jul. 15, 2013, issued in U.S. Appl. No. 13/315,123.
U.S. Notice of Allowance, dated Nov. 8, 2013, issued in U.S. Appl. No. 13/315,123.
U.S. Office Action, dated Nov. 8, 2013, issued in U.S. Appl. No. 13/313,735.
U.S. Final Office Action, dated Jul. 29, 2014, issued in U.S. Appl. No. 13/313,735.
U.S. Office Action, dated Oct. 10, 2014, issued in U.S. Appl. No. 13/313,735.
U.S. Office Action, dated Apr. 20, 2015, issued in U.S. Appl. No. 13/313,735.
U.S. Office Action, dated Oct. 22, 2015, issued in U.S. Appl. No. 13/313,735.
U.S. Final Office Action, dated Feb. 19, 2016, issued in U.S. Appl. No. 13/313,735.
U.S. Office Action, dated Jul. 29, 2016, issued in U.S. Appl. No. 13/329,078.
U.S. Notice of Allowance, dated Mar. 22, 2017, issued in U.S. Appl. No. 13/329,078.
U.S. Office Action, dated Sep. 12, 2013, issued in U.S. Appl. No. 13/493,936.
U.S. Final Office Action, dated Feb. 3, 2014, issued in U.S. Appl. No. 13/493,936.
U.S. Notice of Allowance, dated May 22, 2014, issued in U.S. Appl. No. 13/493,936.
U.S. Office Action, dated Dec. 9, 2014, issued in U.S. Appl. No. 14/466,222.
U.S. Final Office Action, dated Jul. 14, 2015, issued in U.S. Appl. No. 14/466,222.
U.S. Notice of Allowance, dated Oct. 23, 2015, issued in U.S. Appl. No. 14/466,222.
Japanese Office Action dated Sep. 17, 2013 issued in JP2009-282737.
Japanese Office Action dated Jun. 3, 2014 issued in JP2009-282737.
Korean Office Action dated Dec. 27, 2015 issued in KR 10-2009-0124466.
Korean Office Action dated Jul. 12, 2016 issued in KR 10-2009-0124466.
PCT International Search Report and Written Opinion dated Aug. 10, 2011 issued in PCT/US2010/059721.
PCT International Preliminary Report on Patentability and Written Opinion dated Jun. 21, 2012 issued in PCT/US2010/059721.
Chinese First Office Action dated Feb. 8, 2014 issued in CN 2010-80055670.3.
Chinese Second Office Action dated Dec. 15, 2014 issued in CN 2010-80055670.3.
Chinese Third Office Action and Search Report dated Jun. 23, 2015 issued in CN 2010-80055670.3.
Chinese Fourth Office Action dated Mar. 14, 2016 issued in CN 2010-80055670.3.
Korean Office Action dated Nov. 1, 2016 issued in KR 10-2012-7013775.
Taiwan Office Action dated Jun. 12, 2015 issued in TW 099143081.
Taiwan Office Action dated Dec. 10, 2015 issued in TW 099143081.
Chinese First Office Action and Search Report dated Dec. 18, 2014 issued in CN 201110424193.X.
Chinese Second Office Action and Search Report dated Sep. 14, 2015 issued in CN 201110424193.X.
Taiwan Office Action dated Apr. 20, 2016 issued in TW 100145389.
Chinese First Office Action and Search Report dated Jan. 6, 2015 issued in CN 201110442926.2.
Chinese Second Office Action and Search Report dated Aug. 25, 2015 issued in CN 201110442926.2.
Korean First Office Action dated Oct. 24, 2018 issued in KR 10-2011-0138180.
Korean Decision for Grant of Patent dated May 20, 2019 issued in KR 10-2011-0138180.
Taiwan Office Action dated Nov. 20, 2015 issued in TW 100147521.
Taiwan First Office Action Dated Apr. 3, 2018 issued in TW 105136948.
Korean First Office Action dated Apr. 24, 2019 issued in KR 10-2013-0023634.
Taiwan Office Action and Search Report dated Nov. 16, 2016 issued in TW 102107721.
Taiwan Second Office Action [Decision of Refusal] dated Mar. 9, 2018 issued in TW 102107721.
Chinese Second Office Action dated Aug. 14, 2018 issued in CN 201510516169.7.
Chinese First Office Action dated Dec. 13, 2017 issued in CN 20170801752910.
Taiwan First Office Action dated Mar. 20, 2019 issued in TW 104126946.
Korean First Office Action dated Dec. 18, 2017 issued in KR 10-2011-0131725.
Taiwan First Office Action dated Jul. 3, 2018 issued in TW 103136878.
Taiwan First Office Action dated May 25, 2018 issued in TW 103136882.
Bekiari, V. et al. (1998) “Characterization of Photoluminescence from a Material Made by Interaction of (3-Aminopropyl)triethoxysilane with Acetic Acid,” Langmuir, 14(13):3459-3461.
Brankova et al. (2003) “Photoluminescence from Sol-Gel Organic/Inorganic Hybrid Gels Obtained through Carboxylic Acid Solvolysis,” Chem. Mater., 15(9):1855-1859.
Chung, Sung-Woong et al. (Mar. 2004) “Flowable Oxide CVD Process For Shallow Trench Isolation in Silicon Semiconductor,” Journal of Semiconductor Technology and Science, 4(1):45-51.
Chung, Sung-Woong, et al. (2002) “Novel Shallow Trench Isolation Process Using Flowable Oxide CVD for sub-100nm DRAM,” IEEE, IEDM, pp. 233-236.
Fessenden et al. (1961) “The Chemistry of Silicon-Nitrogen Compounds,” Chem. Rev. 61(4)361-388.
Hatanaka, M., et al. (Jun. 11-12, 1991) “H2O-TEOS Plasma-CVD Realizing Dielectrics Having a Smooth Surface,” IEEE, VMIC Conference, pp. 435-441.
Kessler et al. (2006) “New insight in the role of modifying ligands in the sol-gel processing of metal alkoxide precursors: A possibility to approach new classes of materials,” J. Sol-Gel Sci. Techn. 40(2-3):163-179.
Matsuura, M., et al. (1994) “Novel Self-Planarizing CVD Oxide for Interlayer Dielectric Applications,” IEEE, pp. 117-120.
Nakano, M., et al. (1989) “Digital CVD of SiO2,” Extended Abstracts of the 21st Conference on Solid State Devices and Materials, Tokyo, pp. 49-52.
Noguchi, S. et al. (1987) “Liquid Phase Oxidation Employing O Atoms Produced by Microwave Discharge and Si(CH3)4,” Extended Abstracts of the 19th Conference on Solid State Devices and Materials, Tokyo, pp. 451-454.
Sakaue, H., et al. (1991) “Digital Chemical Vapor Deposition of SiO2 Using a Repetitive Reaction of Triethylsilane /Hydrogen and Oxidation,” Department of Electrical Engineering, Hiroshima University, Japanese Journal of Applied Physics, 30(1B):L124-L127.
Stathatos et al. (Jul. 19, 2003) “Study of Acetic Acid-Catalyzed Nanocomposite Organic/Inorganic Ureasil Sol-Gel Ionic Conductors,” Langmuir, 19:(18)7587-7591.
Weast, (1975) “CRC Handbook of Chemistry and Physics,” 56th edition, CRC Press, Cleveland, Ohio, excerpts from F-95 & F-119, 4 pages.
U.S. Office Action, dated Oct. 3, 2007, issued in U.S. Appl. No. 11/115,576.
U.S. Final Office Action, dated May 2, 2008, issued in U.S. Appl. No. 11/115,576.
U.S. Office Action, dated Oct. 17, 2008, issued in U.S. Appl. No. 11/115,576.
U.S. Final Office Action, dated Apr. 22, 2009, issued in U.S. Appl. No. 11/115,576.
U.S. Office Action, dated Oct. 1, 2009, issued in U.S. Appl. No. 11/115,576.
U.S. Final Office Action, dated Apr. 15, 2010, issued in U.S. Appl. No. 11/115,576.
U.S. Office Action, dated Oct. 1, 2010, issued in U.S. Appl. No. 11/115,576.
U.S. Final Office Action, dated May 9, 2011, issued in U.S. Appl. No. 11/115,576.
U.S. Notice of Allowance, dated Nov. 14, 2011, issued in U.S. Appl. No. 11/115,576.
U.S. Office Action, dated Oct. 23, 2012, issued in U.S. Appl. No. 13/370,579.
U.S. Office Action, dated Jun. 4, 2013, issued in U.S. Appl. No. 13/370,579.
U.S. Final Office Action, dated Jan. 27, 2014, issued in U.S. Appl. No. 13/370,579.
U.S. Office Action, dated Apr. 25, 2014, issued in U.S. Appl. No. 13/370,579.
U.S. Notice of Allowance, dated Sep. 25, 2014, issued in U.S. Appl. No. 13/370,579.
U.S. Notice of Allowance, dated Nov. 24, 2014, issued in U.S. Appl. No. 13/370,579.
U.S. Office Action, dated Jun. 11, 2009, issued in U.S. Appl. No. 11/688,695.
U.S. Final Office Action, dated Dec. 31, 2009, issued in U.S. Appl. No. 11/688,695.
U.S. Office Action, dated Jul. 23, 2010, issued in U.S. Appl. No. 11/688,695.
U.S. Final Office Action, dated Feb. 1, 2011, issued in U.S. Appl. No. 11/688,695.
U.S. Office Action, dated Dec. 14, 2011, issued in U.S. Appl. No. 11/688,695.
U.S. Final Office Action, dated Jun. 21, 2012, issued in U.S. Appl. No. 11/688,695.
U.S. Notice of Allowance, dated Oct. 4, 2012, issued in U.S. Appl. No. 11/688,695.
U.S. Notice of Allowance, dated Feb. 14, 2013, issued in U.S. Appl. No. 11/688,695.
U.S. Office Action (Ex Parte Quayle), dated Jul. 19, 2013, issued in U.S. Appl. No. 13/886,694.
U.S. Notice of Allowance, dated Sep. 12, 2013, issued in U.S. Appl. No. 13/886,694.
U.S. Office Action, dated May 31, 2012, issued in U.S. Appl. No. 12/726,263.
U.S. Final Office Action, dated Sep. 10, 2012, issued in U.S. Appl. No. 12/726,263.
U.S. Office Action, dated Mar. 6, 2013, issued in U.S. Appl. No. 12/726,263.
U.S. Final Office Action, dated Aug. 7, 2013, issued in U.S. Appl. No. 12/726,263.
U.S. Office Action dated Jul. 11, 2011 issued in U.S. Appl. No. 11/897,838.
U.S. Notice of Allowance dated Mar. 2, 2012 issued in U.S. Appl. No. 11/897,838.
U.S. Office Action, dated Jan. 3, 2013, issued in U.S. Appl. No. 13/487,051.
U.S. Notice of Allowance, dated Apr. 22, 2013, issued in U.S. Appl. No. 13/487,051.
U.S. Office Action, dated May 20, 2011, issued in U.S. Appl. No. 12/001,348.
U.S. Office Action, dated Nov. 25, 2011, issued in U.S. Appl. No. 12/001,348.
U.S. Office Action, dated Mar. 26, 2012, issued in U.S. Appl. No. 12/001,348.
U.S. Final Office Action, dated Aug. 15, 2012, issued in U.S. Appl. No. 12/001,348.
U.S. Notice of Allowance, dated Dec. 5, 2012, issued in U.S. Appl. No. 12/001,348.
U.S. Office Action, dated Mar. 17, 2010, issued in U.S. Appl. No. 12/008,149.
U.S. Notice of Allowance, dated Nov. 19, 2010, issued in U.S. Appl. No. 12/008,149.
U.S. Notice of Allowance, dated Jun. 7, 2012, issued in U.S. Appl. No. 13/070,306.
U.S. Office Action, dated Nov. 19, 2010, issued in U.S. Appl. No. 12/132,559.
U.S. Final Office Action, dated Jun. 9, 2011, issued in U.S. Appl. No. 12/132,559.
U.S. Office Action, dated Nov. 22, 2011, issued in U.S. Appl. No. 12/132,559.
U.S. Office Action, dated Mar. 22, 2012, issued in U.S. Appl. No. 12/132,559.
U.S. Final Office Action, dated Jul. 12, 2012, issued in U.S. Appl. No. 12/132,559.
U.S. Notice of Allowance, dated Oct. 25, 2012, issued in U.S. Appl. No. 12/132,559.
U.S. Notice of Allowance, dated Feb. 11, 2013, issued in U.S. Appl. No. 12/132,559.
U.S. Office Action, dated Aug. 6, 2014, issued in U.S. Appl. No. 13/776,527.
US Notice of Allowance, dated Mar. 2, 2015, issued in U.S. Appl. No. 13/776,527.
U.S. Office Action, dated Aug. 7, 2017, issued in U.S. Appl. No. 14/717,806.
U.S. Notice of Allowance dated Mar. 2, 2018 in U.S. Appl. No. 14/717,806.
U.S. Appl. No. 12/986,070, filed Jan. 6, 2011, Wang et al.
U.S. Appl. No. 11/561,834, filed Nov. 20, 2006, Kamian et al.
U.S. Appl. No. 11/391,134, filed Mar. 28, 2006, Smargiassi et al.
U.S. Office Action, dated Nov. 25, 2011, issued in U.S. Appl. No. 12/986,070.
U.S. Final Office Action, dated Jun. 25, 2012, issued in U.S. Appl. No. 12/986,070.
U.S. Office Action, dated May 21, 2010, issued in U.S. Appl. No. 11/561,834.
U.S. Final Office Action, dated Dec. 3, 2010, issued in U.S. Appl. No. 11/561,834.
U.S. Office Action, dated Sep. 24, 2007, issued in U.S. Appl. No. 11/391,134.
U.S. Final Office Action, dated Mar. 10, 2008, issued in U.S. Appl. No. 11/391,134.
U.S. Office Action, dated Jul. 9, 2008, issued in U.S. Appl. No. 11/391,134.
U.S. Final Office Action, dated Sep. 25, 2008, issued in U.S. Appl. No. 11/391,134.
U.S. Office Action, dated Feb. 10, 2009, issued in U.S. Appl. No. 11/391,134.
Korean First Office Action dated Jul. 30, 2018 issued in Application No. KR 10-2012-0029915.
Korean Second Office Action dated Mar. 17, 2019 issued in Application No. KR 10-2012-0029915.
Korean First Office Action dated Feb. 26, 2021 issued in KR 10-2014-0146464.
Taiwan First Office Action dated May 7, 2020 issued in TW 105137199.
U.S. Office Action dated Jan. 25, 2021 issued in U.S. Appl. No. 16/029,471.
Related Publications (1)
Number Date Country
20190333790 A1 Oct 2019 US
Continuations (1)
Number Date Country
Parent 14942703 Nov 2015 US
Child 16509236 US